BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL;  IOF Bone and Diabetes Working Group. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13:208-219. [PMID: 27658727 DOI: 10.1038/nrendo.2016.153] [Cited by in Crossref: 339] [Cited by in F6Publishing: 308] [Article Influence: 56.5] [Reference Citation Analysis]
Number Citing Articles
1 Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero JJ, Dakal S, Franconi F, Gouni-Berthold I, Heiman ML, Kautzky-Willer A, Klein SL, Murphy A, Regitz-Zagrosek V, Reue K, Rubin JB. Sex- and Gender-Based Pharmacological Response to Drugs. Pharmacol Rev 2021;73:730-62. [PMID: 33653873 DOI: 10.1124/pharmrev.120.000206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
2 Botella Martínez S, Petrina Jauregui E, Escalada San Martín J. Impact of bariatric surgery on bone tissue. Endocrinol Diabetes Nutr (Engl Ed) 2019;66:62-8. [PMID: 30266592 DOI: 10.1016/j.endinu.2018.06.009] [Reference Citation Analysis]
3 Mabilleau G, Pereira M, Chenu C. Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists. J Endocrinol 2018;236:R29-42. [PMID: 28855317 DOI: 10.1530/JOE-17-0278] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
4 Cheng L, Hu Y, Li YY, Cao X, Bai N, Lu TT, Li GQ, Li N, Wang AN, Mao XM. Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Diabetes Metab Res Rev 2019;35:e3168. [PMID: 30974033 DOI: 10.1002/dmrr.3168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
5 Vavanikunnel J, Charlier S, Becker C, Schneider C, Jick SS, Meier CR, Meier C. Association Between Glycemic Control and Risk of Fracture in Diabetic Patients: A Nested Case-Control Study. J Clin Endocrinol Metab. 2019;104:1645-1654. [PMID: 30657918 DOI: 10.1210/jc.2018-01879] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
6 Zhu B, Lin Z, Chen X, Gusdon AM, Shen W, Chen J, Zheng L, Sun H, Li Y, Zhu C, Li J, Qu S. Circulating osteocalcin: A potential predictor of ketosis in type 2 diabetes. Diabetes Metab Res Rev 2020;36:e3265. [PMID: 31850672 DOI: 10.1002/dmrr.3265] [Reference Citation Analysis]
7 Wang Y, Huang L, Qin Z, Yuan H, Li B, Pan Y, Wang X, Du X, Hao S, Du Y, Wang R, Shen Y. Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling. IUBMB Life 2021;73:213-22. [PMID: 33249758 DOI: 10.1002/iub.2420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wang H, Fu X, Shi J, Li L, Sun J, Zhang X, Han Q, Deng Y, Gan X. Nutrient Element Decorated Polyetheretherketone Implants Steer Mitochondrial Dynamics for Boosted Diabetic Osseointegration. Adv Sci (Weinh) 2021;8:e2101778. [PMID: 34396715 DOI: 10.1002/advs.202101778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
9 Thangavelu T, Silverman E, Akhter MP, Lyden E, Recker RR, Graeff-Armas LA. Trabecular bone score and transilial bone trabecular histomorphometry in type 1 diabetes and healthy controls. Bone 2020;137:115451. [PMID: 32450341 DOI: 10.1016/j.bone.2020.115451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Liu XX, Jiang L, Liu Q, Zhang J, Niu W, Liu J, Zhang Q. Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus. J Diabetes Res 2020;2020:6191468. [PMID: 32851096 DOI: 10.1155/2020/6191468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Papaioannou I, Pantazidou G, Kokkalis Z, Georgopoulos N, Jelastopulu E. Systematic Review: Are the Elderly With Diabetes Mellitus Type 2 Prone to Fragility Fractures? Cureus 2021;13:e14514. [PMID: 34007765 DOI: 10.7759/cureus.14514] [Reference Citation Analysis]
12 Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D. Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry. J Bone Miner Res. 2018;33:1923-1930. [PMID: 29953670 DOI: 10.1002/jbmr.3538] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
13 Stage TB, Christensen MH, Jørgensen NR, Beck-Nielsen H, Brøsen K, Gram J, Frost M. Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes. Bone 2018;112:35-41. [PMID: 29654849 DOI: 10.1016/j.bone.2018.04.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
14 Tao Y, E M, Shi J, Zhang Z. Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study. Aging Clin Exp Res 2021;33:2133-9. [PMID: 33104983 DOI: 10.1007/s40520-020-01736-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Koromani F, Ghatan S, van Hoek M, Zillikens MC, Oei EHG, Rivadeneira F, Oei L. Type 2 Diabetes Mellitus and Vertebral Fracture Risk. Curr Osteoporos Rep 2021;19:50-7. [PMID: 33432548 DOI: 10.1007/s11914-020-00646-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Liu JM, Zhu DL, Mu YM, Xia WB;  Chinese Society of Osteoporosis and Bone Mineral Research; the Chinese Society of Endocrinology, Chinese Diabetes Society, Chinese Medical Association;  Chinese Endocrinologist Association;  Chinese Medical Doctor Association. Management of fracture risk in patients with diabetes-Chinese Expert Consensus. J Diabetes. 2019;11:906-919. [PMID: 31219236 DOI: 10.1111/1753-0407.12962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Suchacki KJ, Roberts F, Lovdel A, Farquharson C, Morton NM, MacRae VE, Cawthorn WP. Skeletal energy homeostasis: a paradigm of endocrine discovery. J Endocrinol 2017;234:R67-79. [PMID: 28455432 DOI: 10.1530/JOE-17-0147] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
18 Veldhuis-Vlug AG, Rosen CJ. Clinical implications of bone marrow adiposity. J Intern Med 2018;283:121-39. [PMID: 29211319 DOI: 10.1111/joim.12718] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 19.3] [Reference Citation Analysis]
19 Gortázar AR, Ardura JA. Osteocytes and Diabetes: Altered Function of Diabetic Osteocytes. Curr Osteoporos Rep 2020;18:796-802. [DOI: 10.1007/s11914-020-00641-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ruppert K, Cauley J, Lian Y, Zgibor JC, Derby C, Solomon DH. The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study. Osteoporos Int 2018;29:347-54. [PMID: 29075805 DOI: 10.1007/s00198-017-4276-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
21 Li S, Qui Y, Teng Z, Chen J, Kang D, Tang H, Xiang H, Wu C, Tan Y, Wang L, Yang Y, Wang B, Wu H. Association Between Bipolar Disorder and Low Bone Mass: A Cross-Sectional Study With Newly Diagnosed, Drug-Naïve Patients. Front Psychiatry 2020;11:530. [PMID: 32587534 DOI: 10.3389/fpsyt.2020.00530] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kushwaha P, Wolfgang MJ, Riddle RC. Fatty acid metabolism by the osteoblast. Bone 2018;115:8-14. [PMID: 28863948 DOI: 10.1016/j.bone.2017.08.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
23 Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management. Endocr Rev 2019;40:333-68. [PMID: 30169557 DOI: 10.1210/er.2018-00001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 24.0] [Reference Citation Analysis]
24 Wang G, Zhang J, Zhang K, Zhao Q, Zhou F, Xu J, Xue W, Zhang C, Fu C. Possible action mechanisms of vitamin D supplementation in combating obesity and obesity-related issues of bone health: a mini review. Food Sci Technol 2022;42:e114621. [DOI: 10.1590/fst.114621] [Reference Citation Analysis]
25 Lee RH, Sloane R, Pieper C, Lyles KW, Adler RA, Van Houtven C, LaFleur J, Colón-Emeric C. Glycemic Control and Insulin Treatment Alter Fracture Risk in Older Men With Type 2 Diabetes Mellitus. J Bone Miner Res 2019;34:2045-51. [PMID: 31269274 DOI: 10.1002/jbmr.3826] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
26 He H, Zhang Y, Sun Y, Zhang Y, Xu J, Yang Y, Chen J. Folic Acid Attenuates High-Fat Diet-Induced Osteoporosis Through the AMPK Signaling Pathway. Front Cell Dev Biol 2021;9:791880. [PMID: 35047504 DOI: 10.3389/fcell.2021.791880] [Reference Citation Analysis]
27 Zhang P, Zhang H, Lin J, Xiao T, Xu R, Fu Y, Zhang Y, Du Y, Cheng J, Jiang H. Insulin impedes osteogenesis of BMSCs by inhibiting autophagy and promoting premature senescence via the TGF-β1 pathway. Aging (Albany NY) 2020;12:2084-100. [PMID: 32017705 DOI: 10.18632/aging.102723] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
28 Shaik AR, Singh P, Shaik C, Kohli S, Vohora D, Ferrari SL. Metformin: Is It the Well Wisher of Bone Beyond Glycemic Control in Diabetes Mellitus? Calcif Tissue Int 2021;108:693-707. [PMID: 33797562 DOI: 10.1007/s00223-021-00805-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ham JR, Lee HI, Choi RY, Ryu HS, Yee ST, Kang KY, Lee MK. Heshouwu (Polygonum multiflorum Thunb.) Extract Attenuates Bone Loss in Diabetic Mice. Prev Nutr Food Sci 2019;24:121-7. [PMID: 31328115 DOI: 10.3746/pnf.2019.24.2.121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Adami G, Gatti D, Rossini M, Orsolini G, Pollastri F, Bertoldo E, Viapiana O, Bertoldo F, Giollo A, Fassio A. Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort. Osteoporos Int 2020;31:2113-22. [PMID: 32613408 DOI: 10.1007/s00198-020-05519-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
31 Gennari L, Merlotti D, Falchetti A, Eller Vainicher C, Cosso R, Chiodini I. Emerging therapeutic targets for osteoporosis. Expert Opin Ther Targets 2020;24:115-30. [PMID: 32050822 DOI: 10.1080/14728222.2020.1726889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
32 Hu XF, Xiang G, Wang TJ, Ma YB, Zhang Y, Yan YB, Zhao X, Wu ZX, Feng YF, Lei W. Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice. Theranostics 2021;11:3796-812. [PMID: 33664862 DOI: 10.7150/thno.50907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
33 Caffarelli C, Tomai Pitinca MD, Al Refaie A, Ceccarelli E, Gonnelli S. Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging Clin Exp Res 2022;34:121-7. [PMID: 34050917 DOI: 10.1007/s40520-021-01889-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Wang X, Yu J, Wang X, Jing Y, Sun L, Tao B, Wang W, Ning G, Liu J, Zhao H. The Associations Between Hypovitaminosis D, Higher Pth Levels With Bone Mineral Densities, And Risk Of The 10-Year Probability Of Major Osteoporotic Fractures In Chinese Patients With T2Dm. Endocrine Practice 2018;24:334-41. [DOI: 10.4158/ep-2017-0164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
35 Qiu M, Zhai S, Liu D. DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes. Int J Endocrinol 2020;2020:8874272. [PMID: 33312197 DOI: 10.1155/2020/8874272] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Moseley KF, Du Z, Sacher SE, Ferguson VL, Donnelly E. Advanced glycation endproducts and bone quality: practical implications for people with type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2021;28:360-70. [PMID: 34183538 DOI: 10.1097/MED.0000000000000641] [Reference Citation Analysis]
37 Gennari L, Bilezikian JP. New and developing pharmacotherapy for osteoporosis in men. Expert Opinion on Pharmacotherapy 2018;19:253-64. [DOI: 10.1080/14656566.2018.1428559] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
38 Liu C, Lv H, Niu P, Tan J, Ma Y. Association between diabetic neuropathy and osteoporosis in patients: a systematic review and meta-analysis. Arch Osteoporos 2020;15:125. [PMID: 32779030 DOI: 10.1007/s11657-020-00804-6] [Reference Citation Analysis]
39 Puspitasari M, Purnamasari D, Setyohadi B, Isbagio H. Bone Metabolism and Fracture Risk in Diabetes Mellitus. J ASEAN Fed Endocr Soc 2017;32:90-9. [PMID: 33442091 DOI: 10.15605/jafes.032.02.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
40 Dominic E, Brozek W, Peter RS, Fromm E, Ulmer H, Rapp K, Concin H, Nagel G. Metabolic factors and hip fracture risk in a large Austrian cohort study. Bone Rep 2020;12:100244. [PMID: 31970265 DOI: 10.1016/j.bonr.2020.100244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Chen B, Wang L, Li L, Zhu R, Liu H, Liu C, Ma R, Jia Q, Zhao D, Niu J, Fu M, Gao S, Zhang D. Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety. Molecules 2017;22:E1469. [PMID: 28872612 DOI: 10.3390/molecules22091469] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
42 Chandran M. Clinical aspects and management of osteoporosis and fragility fractures in patients with diabetes. Osteoporos Sarcopenia 2017;3:123-7. [PMID: 30775516 DOI: 10.1016/j.afos.2017.08.101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
43 Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, El-Hajj Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD;  Bone and Diabetes Working Group of IOF. Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int. 2018;29:2585-2596. [PMID: 30066131 DOI: 10.1007/s00198-018-4650-2] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 26.0] [Reference Citation Analysis]
44 Zhang Z, Wu H, Huang S, Chen L, Chen X, Zhang W, Liao L, Zhang X. AMD3465 (hexahydrobromide) rescues the MG63 osteoblasts against the apoptosis induced by high glucose. Biomed Pharmacother 2021;138:111476. [PMID: 33773470 DOI: 10.1016/j.biopha.2021.111476] [Reference Citation Analysis]
45 Lenchik L, Register TC, Hsu FC, Xu J, Smith SC, Carr JJ, Freedman BI, Bowden DW. Bone Mineral Density of the Radius Predicts All-Cause Mortality in Patients With Type 2 Diabetes: Diabetes Heart Study. J Clin Densitom 2018;21:347-54. [PMID: 29284565 DOI: 10.1016/j.jocd.2017.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
46 Pieralice S, Vigevano F, Del Toro R, Napoli N, Maddaloni E. Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis. Curr Diab Rep 2018;18:84. [PMID: 30121859 DOI: 10.1007/s11892-018-1060-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Jiang Y, Luo W, Wang B, Yi Z, Gong P, Xiong Y. 1α,25-Dihydroxyvitamin D3 ameliorates diabetes-induced bone loss by attenuating FoxO1-mediated autophagy. J Biol Chem 2021;296:100287. [PMID: 33450223 DOI: 10.1016/j.jbc.2021.100287] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Pal R, Bhadada SK, Mukherjee S, Banerjee M, Kumar A. Fracture risk in hypoparathyroidism: a systematic review and meta-analysis. Osteoporos Int 2021. [PMID: 34021765 DOI: 10.1007/s00198-021-05966-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Ahmad OS, Leong A, Miller JA, Morris JA, Forgetta V, Mujammami M, Richards JB. A Mendelian Randomization Study of the Effect of Type-2 Diabetes and Glycemic Traits on Bone Mineral Density. J Bone Miner Res 2017;32:1072-81. [PMID: 27982478 DOI: 10.1002/jbmr.3063] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
50 Sánchez-de-Diego C, Pedrazza L, Pimenta-Lopes C, Martinez-Martinez A, Dahdah N, Valer JA, Garcia-Roves P, Rosa JL, Ventura F. NRF2 function in osteocytes is required for bone homeostasis and drives osteocytic gene expression. Redox Biol 2021;40:101845. [PMID: 33373776 DOI: 10.1016/j.redox.2020.101845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Zhang C, Wei W, Chi M, Wan Y, Li X, Qi M, Zhou Y. FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions. J Diabetes Res 2019;2019:6757428. [PMID: 31886284 DOI: 10.1155/2019/6757428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
52 Hansen MSS, Tencerova M, Frølich J, Kassem M, Frost M. Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism. Basic Clin Pharmacol Toxicol 2018;122:25-37. [PMID: 28722834 DOI: 10.1111/bcpt.12850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
53 Yoon JH, Hong AR, Choi W, Park JY, Kim HK, Kang HC. Association of Triglyceride-Glucose Index with Bone Mineral Density in Non-diabetic Koreans: KNHANES 2008-2011. Calcif Tissue Int 2021;108:176-87. [PMID: 33006085 DOI: 10.1007/s00223-020-00761-9] [Reference Citation Analysis]
54 Frost M, Balkau B, Hatunic M, Konrad T, Mingrone G, Højlund K. The relationship between bone turnover and insulin sensitivity and secretion: Cross-sectional and prospective data from the RISC cohort study. Bone 2018;108:98-105. [PMID: 29305997 DOI: 10.1016/j.bone.2017.12.029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
55 Jørgensen HS, David K, Salam S, Evenepoel P; European Renal Osteodystrophy (EUROD) workgroup, an initiative of the CKD-MBD working group of the ERA-EDTA. Traditional and Non-traditional Risk Factors for Osteoporosis in CKD. Calcif Tissue Int 2021;108:496-511. [PMID: 33586002 DOI: 10.1007/s00223-020-00786-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Zhang Z, Ren H, Shen G, Zhao W, Shang Q, Yu X, Lu Y, Yu P, Zhang Y, Tang J, Liang D, Jiang X. IGF-1R/β-catenin signaling axis is implicated in streptozotocin exacerbating bone impairment in ovariectomized rats. Climacteric 2021;24:179-86. [PMID: 33000666 DOI: 10.1080/13697137.2020.1816956] [Reference Citation Analysis]
57 Lee J, Han K, Park SH, Kim MK, Lim DJ, Yoon KH, Kang MI, Lee SH. Associations of variability in body weight and glucose levels with the risk of hip fracture in people with diabetes. Metabolism 2022;129:155135. [PMID: 35032546 DOI: 10.1016/j.metabol.2022.155135] [Reference Citation Analysis]
58 Kitaura H, Ogawa S, Ohori F, Noguchi T, Marahleh A, Nara Y, Pramusita A, Kinjo R, Ma J, Kanou K, Mizoguchi I. Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption. Int J Mol Sci 2021;22:6578. [PMID: 34205264 DOI: 10.3390/ijms22126578] [Reference Citation Analysis]
59 Depczynski B, Liew PY, White C. Association of glycaemic variables with trabecular bone score in post-menopausal women with type 2 diabetes mellitus. Diabet Med 2020;37:1545-52. [PMID: 32276299 DOI: 10.1111/dme.14303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Bartstra JW, Draaisma F, Zwakenberg SR, Lessmann N, Wolterink JM, van der Schouw YT, de Jong PA, Beulens JWJ. Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2. Eur J Nutr 2021;60:1691-9. [PMID: 33068157 DOI: 10.1007/s00394-020-02412-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
61 Lauterlein JL, Hermann P, Konrad T, Wolf P, Nilsson P, Sánchez RG, Ferrannini E, Balkau B, Højlund K, Frost M. Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study. Bone 2021;143:115681. [PMID: 33035729 DOI: 10.1016/j.bone.2020.115681] [Reference Citation Analysis]
62 Napoli N, Conte C, Eastell R, Ewing SK, Bauer DC, Strotmeyer ES, Black DM, Samelson EJ, Vittinghoff E, Schwartz AV. Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes. J Bone Miner Res 2020;35:2363-71. [DOI: 10.1002/jbmr.4140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Huang KC, Chuang PY, Yang TY, Huang TW, Chang SF. Hyperglycemia inhibits osteoblastogenesis of rat bone marrow stromal cells via activation of the Notch2 signaling pathway. Int J Med Sci 2019;16:696-703. [PMID: 31217737 DOI: 10.7150/ijms.32707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
64 Napoli N, Schwartz AV, Black DM; Osteoporotic Fractures in Men (MrOS) Study Research Group. Reply to: Indications of Increased Vertebral Fracture Risk in Patients With Type 2 Diabetes. J Bone Miner Res 2018;33:183. [PMID: 29077237 DOI: 10.1002/jbmr.3322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Brunetti G, D'Amato G, De Santis S, Grano M, Faienza MF. Mechanisms of altered bone remodeling in children with type 1 diabetes. World J Diabetes 2021; 12(7): 997-1009 [PMID: 34326950 DOI: 10.4239/wjd.v12.i7.997] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Huang JF, Wu QN, Zheng XQ, Sun XL, Wu CY, Wang XB, Wu CW, Wang B, Wang XY, Bergman M, Wu AM. The Characteristics and Mortality of Osteoporosis, Osteomyelitis, or Rheumatoid Arthritis in the Diabetes Population: A Retrospective Study. Int J Endocrinol 2020;2020:8821978. [PMID: 33224196 DOI: 10.1155/2020/8821978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Xu Y, Wu Q. Trends in osteoporosis and mean bone density among type 2 diabetes patients in the US from 2005 to 2014. Sci Rep 2021;11:3693. [PMID: 33580184 DOI: 10.1038/s41598-021-83263-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Hu Z, Qiu W, Yu Y, Wu X, Fang F, Zhu X, Xu X, Tu Q, Van Dyke TE, Morgan EF, Chen J. Identification and Characterization of a Novel Long Noncoding RNA that Regulates Osteogenesis in Diet-Induced Obesity Mice. Front Cell Dev Biol 2022;10:832460. [DOI: 10.3389/fcell.2022.832460] [Reference Citation Analysis]
69 Ross BJ, Lee OC, Harris MB, Dowd TC, Savoie FH 3rd, Sherman WF. The Impact of Diabetes on Osteoporosis Management and Secondary Fracture Risk After Primary Fragility Fractures: A Propensity Score-Matched Cohort Study. J Am Acad Orthop Surg 2021. [PMID: 34543247 DOI: 10.5435/JAAOS-D-21-00185] [Reference Citation Analysis]
70 Lekkala S, Taylor EA, Hunt HB, Donnelly E. Effects of Diabetes on Bone Material Properties. Curr Osteoporos Rep 2019;17:455-64. [PMID: 31713179 DOI: 10.1007/s11914-019-00538-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
71 Lee ES, Lim J, Cho J, Jung H, Choi J, Park S, Kim Y, Ro H, Lee S, Han S, Jung CW, Park JB, Kim MS, Yang J, Ahn C, Kim C. Pretransplant Osteoporosis and Osteopenia are Risk Factors for Fractures After Kidney Transplantation. Transplantation Proceedings 2019;51:2704-9. [DOI: 10.1016/j.transproceed.2019.03.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
72 Ha J, Lim Y, Kim MK, Kwon HS, Song KH, Ko SH, Kang MI, Moon SD, Baek KH. Comparison of the Effects of Various Antidiabetic Medication on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul) 2021;36:895-903. [PMID: 34365776 DOI: 10.3803/EnM.2021.1026] [Reference Citation Analysis]
73 Sun Y, Zhu Y, Liu X, Chai Y, Xu J. Morroniside attenuates high glucose-induced BMSC dysfunction by regulating the Glo1/AGE/RAGE axis. Cell Prolif 2020;53:e12866. [PMID: 32643284 DOI: 10.1111/cpr.12866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
74 Liu L, Wang X, Zhou Y, Cai M, Lin K, Fang B, Xia L. The synergistic promotion of osseointegration by nanostructure design and silicon substitution of hydroxyapatite coatings in a diabetic model. J Mater Chem B 2020;8:2754-67. [PMID: 32196041 DOI: 10.1039/c9tb02882j] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
75 Bilinski WJ, Paradowski PT, Sypniewska G. Bone health and hyperglycemia in pediatric populations. Crit Rev Clin Lab Sci 2020;57:444-57. [PMID: 32216595 DOI: 10.1080/10408363.2020.1739619] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Agarwal A, Leslie WD. Fracture prediction tools in diabetes. Curr Opin Endocrinol Diabetes Obes 2022. [PMID: 35749735 DOI: 10.1097/MED.0000000000000734] [Reference Citation Analysis]
77 Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott BT, Dillmann W, Sah RL, Casteel DE, Pilz RB. Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 2018;67:607-23. [PMID: 29301852 DOI: 10.2337/db17-0965] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
78 Chen YS, Lian WS, Kuo CW, Ke HJ, Wang SY, Kuo PC, Jahr H, Wang FS. Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development. Int J Mol Sci 2020;21:E4923. [PMID: 32664681 DOI: 10.3390/ijms21144923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Shen CL, Kaur G, Wanders D, Sharma S, Tomison MD, Ramalingam L, Chung E, Moustaid-Moussa N, Mo H, Dufour JM. Annatto-extracted tocotrienols improve glucose homeostasis and bone properties in high-fat diet-induced type 2 diabetic mice by decreasing the inflammatory response. Sci Rep 2018;8:11377. [PMID: 30054493 DOI: 10.1038/s41598-018-29063-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
80 Kumari C, Yagoub G, Ashfaque M, Jawed S, Hamid P. Consequences of Diabetes Mellitus in Bone Health: Traditional Review. Cureus 2021;13:e13820. [PMID: 33850676 DOI: 10.7759/cureus.13820] [Reference Citation Analysis]
81 Cheng L, Li Y, Hu W, Bai F, Hao H, Yu W, Mao X. Risk of bone fracture associated with sodium–glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials. Diabetes & Metabolism 2019;45:436-45. [DOI: 10.1016/j.diabet.2019.01.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
82 Daamouch S, Emini L, Rauner M, Hofbauer LC. MicroRNA and Diabetic Bone Disease. Curr Osteoporos Rep 2022;20:194-201. [PMID: 35672565 DOI: 10.1007/s11914-022-00731-0] [Reference Citation Analysis]
83 Long M, Li X, Li L, Dodson M, Zhang DD, Zheng H. Multifunctional p62 Effects Underlie Diverse Metabolic Diseases. Trends Endocrinol Metab 2017;28:818-30. [PMID: 28966079 DOI: 10.1016/j.tem.2017.09.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
84 Turecamo SE, Walji TA, Broekelmann TJ, Williams JW, Ivanov S, Wee NK, Procknow JD, McManus MR, Randolph GJ, Scheller EL, Mecham RP, Craft CS. Contribution of metabolic disease to bone fragility in MAGP1-deficient mice. Matrix Biol 2018;67:1-14. [PMID: 29519758 DOI: 10.1016/j.matbio.2018.02.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
85 Ramdani G, Schall N, Kalyanaraman H, Wahwah N, Moheize S, Lee JJ, Sah RL, Pfeifer A, Casteel DE, Pilz RB. cGMP-dependent protein kinase-2 regulates bone mass and prevents diabetic bone loss. J Endocrinol 2018;238:203-19. [PMID: 29914933 DOI: 10.1530/JOE-18-0286] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
86 Tao S, Li X, Wei W, Wei Z, Zhang C, Wang F, Dawes H, Guo S. Polymeric coating on β-TCP scaffolds provides immobilization of small extracellular vesicles with surface-functionalization and ZEB1-Loading for bone defect repair in diabetes mellitus. Biomaterials 2022;283:121465. [DOI: 10.1016/j.biomaterials.2022.121465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Costantini S, Conte C. Bone health in diabetes and prediabetes. World J Diabetes 2019; 10(8): 421-445 [PMID: 31523379 DOI: 10.4239/wjd.v10.i8.421] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
88 Lee HS, Hwang JS. Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism. Curr Diab Rep 2020;20. [DOI: 10.1007/s11892-020-01361-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
89 Lou Y, Yu Y, Duan J, Bi S, Swe KNC, Xi Z, Gao Y, Zhou Y, Nie X, Liu W. Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Ther Adv Chronic Dis 2020;11:2040622320961599. [PMID: 33062238 DOI: 10.1177/2040622320961599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
90 Mesinovic J, Mcmillan LB, Shore‐lorenti C, Zengin A, De Courten B, Ebeling PR, Scott D. Sex‐specific associations between insulin resistance and bone parameters in overweight and obese older adults. Clin Endocrinol 2019;90:680-9. [DOI: 10.1111/cen.13947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Shen D, Yu H, Wang L, Khan A, Haq F, Chen X, Huang Q, Teng L. Recent progress in design and preparation of glucose-responsive insulin delivery systems. Journal of Controlled Release 2020;321:236-58. [DOI: 10.1016/j.jconrel.2020.02.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
92 Zhu Q, Xu J, Zhou M, Lian X, Shi J. Association between type 1 diabetes mellitus and reduced bone mineral density in children: a meta-analysis. Osteoporos Int. 2021;. [PMID: 33404757 DOI: 10.1007/s00198-020-05715-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Vigevano F, Gregori G, Colleluori G, Chen R, Autemrongsawat V, Napoli N, Qualls C, Villareal DT, Armamento-Villareal R. In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength and Low Bone Turnover. J Clin Endocrinol Metab 2021;106:1362-76. [PMID: 33537757 DOI: 10.1210/clinem/dgab061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Joad S, Ballato E, Deepika F, Gregori G, Fleires-Gutierrez AL, Colleluori G, Aguirre L, Chen R, Russo V, Fuenmayor Lopez VC, Qualls C, Villareal DT, Armamento-Villareal R. Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2021;12:788107. [PMID: 35027909 DOI: 10.3389/fendo.2021.788107] [Reference Citation Analysis]
95 Zhao H, Qi C, Zheng C, Gan K, Ren L, Song G. Effects of Glycated Hemoglobin Level on Bone Metabolism Biomarkers in Patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2020;13:1785-91. [PMID: 32547140 DOI: 10.2147/DMSO.S248844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Bjørnshave A, Lykkeboe S, Hartmann B, Holst JJ, Hermansen K, Starup-Linde J. Effects of a whey protein pre-meal on bone turnover in participants with and without type 2 diabetes-A post hoc analysis of a randomised, controlled, crossover trial. Diabet Med 2021;38:e14471. [PMID: 33259643 DOI: 10.1111/dme.14471] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Karner CM, Long F. Glucose metabolism in bone. Bone 2018;115:2-7. [PMID: 28843700 DOI: 10.1016/j.bone.2017.08.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
98 Hamilton EJ, Drinkwater JJ, Chubb SAP, Rakic V, Kamber N, Zhu K, Prince RL, Davis WA, Davis TME. A 10-Year Prospective Study of Bone Mineral Density and Bone Turnover in Males and Females With Type 1 Diabetes. J Clin Endocrinol Metab. 2018;103:3531-3539. [PMID: 30032248 DOI: 10.1210/jc.2018-00850] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
99 Li DD, Yang Y, Gao ZY, Zhao LH, Yang X, Xu F, Yu C, Zhang XL, Wang XQ, Wang LH, Su JB. Sedentary lifestyle and body composition in type 2 diabetes. Diabetol Metab Syndr 2022;14:8. [PMID: 35033170 DOI: 10.1186/s13098-021-00778-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Aleti S, Pal R, Dutta P, Dhibar DP, Prakash M, Khandelwal N, Dhiman V, Bhadada SK. Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India. Int J Diabetes Dev Ctries 2020;40:262-8. [DOI: 10.1007/s13410-019-00786-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Guo J, Dong W, Jin L, Wang P, Hou Z, Zhang Y. Hydrogen-rich saline prevents bone loss in diabetic rats induced by streptozotocin. Int Orthop 2017;41:2119-28. [PMID: 28748382 DOI: 10.1007/s00264-017-3581-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
102 Yang K, Miao H, Zhao R, Wu X, Liu B, Zheng S, Huang D, Ping Z. Association between serum uric acid and bone mineral density in patients with type 2 diabetes: A 6-year longitudinal study in China. Medicine (Baltimore) 2021;100:e25733. [PMID: 33907167 DOI: 10.1097/MD.0000000000025733] [Reference Citation Analysis]
103 Ma H, Wang X, Zhang W, Li H, Zhao W, Sun J, Yang M. Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Oxid Med Cell Longev 2020;2020:9067610. [PMID: 33343809 DOI: 10.1155/2020/9067610] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
104 Alliston T, Schafer A. Bone Quality Sleuths: Uncovering Tissue-Level Mechanisms of Bone Fragility in Human Type 2 Diabetes. J Bone Miner Res 2019;34:1189-90. [PMID: 31225923 DOI: 10.1002/jbmr.3749] [Reference Citation Analysis]
105 Murray CE, Coleman CM. Impact of Diabetes Mellitus on Bone Health. Int J Mol Sci 2019;20:E4873. [PMID: 31575077 DOI: 10.3390/ijms20194873] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
106 Karim K, Giribabu N, Salleh N. Marantodes pumilum Var Alata (Kacip Fatimah) ameliorates derangement in RANK/RANKL/OPG pathway and reduces inflammation and oxidative stress in the bone of estrogen-deficient female rats with type-2 diabetes. Phytomedicine 2021;91:153677. [PMID: 34333329 DOI: 10.1016/j.phymed.2021.153677] [Reference Citation Analysis]
107 Haraguchi A, Shigeno R, Horie I, Morimoto S, Ito A, Chiba K, Kawazoe Y, Tashiro S, Miyamoto J, Sato S, Yamamoto H, Osaki M, Kawakami A, Abiru N. The effect of luseogliflozin on bone microarchitecture in older patients with type 2 diabetes: study protocol for a randomized controlled pilot trial using second-generation, high-resolution, peripheral quantitative computed tomography (HR-pQCT). Trials 2020;21:379. [PMID: 32370806 DOI: 10.1186/s13063-020-04276-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Mathiesen IH, Hitz MF, Katzenstein TL, Oturai P, Skov M, Jørgensen NR, Jensen PO, Mikkelsen CR, Krogh-Madsen R, Pressler T, Faurholt-Jepsen D. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose. J Cyst Fibros 2019;18:436-41. [PMID: 30928333 DOI: 10.1016/j.jcf.2019.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
109 Qi SS, Shao ML, Sun Z, Chen SM, Hu YJ, Li XS, Chen J, Zheng HX, Yue TL. Chondroitin Sulfate Alleviates Diabetic Osteoporosis and Repairs Bone Microstructure via Anti-Oxidation, Anti-Inflammation, and Regulating Bone Metabolism. Front Endocrinol (Lausanne) 2021;12:759843. [PMID: 34777254 DOI: 10.3389/fendo.2021.759843] [Reference Citation Analysis]
110 Yang J, Hong N, Shim JS, Rhee Y, Kim HC. Association of Insulin Resistance with Lower Bone Volume and Strength Index of the Proximal Femur in Nondiabetic Postmenopausal Women. J Bone Metab. 2018;25:123-132. [PMID: 29900162 DOI: 10.11005/jbm.2018.25.2.123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
111 Valentini A, Cianfarani MA, Federici M, Tarantino U, Bertoli A. Osteoprotegerin in diabetic osteopathy. Nutr Metab Cardiovasc Dis 2020;30:49-55. [PMID: 31757570 DOI: 10.1016/j.numecd.2019.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Hu L, Li T, Zou Y, Yin XL, Gan H. The Clinical Value of the RA-Adjusted Fracture Risk Assessment Tool in the Fracture Risk Prediction of Patients with Type 2 Diabetes Mellitus in China. Int J Gen Med 2021;14:327-33. [PMID: 33542649 DOI: 10.2147/IJGM.S296399] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Hunt HB, Torres AM, Palomino PM, Marty E, Saiyed R, Cohn M, Jo J, Warner S, Sroga GE, King KB, Lane JM, Vashishth D, Hernandez CJ, Donnelly E. Altered Tissue Composition, Microarchitecture, and Mechanical Performance in Cancellous Bone From Men With Type 2 Diabetes Mellitus. J Bone Miner Res 2019;34:1191-206. [PMID: 30866111 DOI: 10.1002/jbmr.3711] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
114 Eller-Vainicher C, Cairoli E, Grassi G, Grassi F, Catalano A, Merlotti D, Falchetti A, Gaudio A, Chiodini I, Gennari L. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility. J Diabetes Res 2020;2020:7608964. [PMID: 32566682 DOI: 10.1155/2020/7608964] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
115 Mesinovic J, Scott D, Seibel MJ, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Waite LM, Handelsman DJ, Hirani V. Risk Factors for Incident Falls and Fractures in Older Men With and Without Type 2 Diabetes Mellitus: The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci 2021;76:1090-100. [PMID: 33649759 DOI: 10.1093/gerona/glab062] [Reference Citation Analysis]
116 Zheng C, Chen J, Liu S, Jin Y. Stem cell-based bone and dental regeneration: a view of microenvironmental modulation. Int J Oral Sci 2019;11:23. [PMID: 31423011 DOI: 10.1038/s41368-019-0060-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 17.7] [Reference Citation Analysis]
117 Napoli N, Strollo R, Defeudis G, Leto G, Moretti C, Zampetti S, D'Onofrio L, Campagna G, Palermo A, Greto V, Manfrini S, Hawa MI, Leslie RD, Pozzilli P, Buzzetti R; NIRAD (NIRAD 10) and Action LADA Study Groups. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults. J Clin Endocrinol Metab 2018;103:1921-8. [PMID: 29506222 DOI: 10.1210/jc.2017-02274] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
118 Wu C, Yu P, Sun R. Adipose tissue and age‑dependent insulin resistance: New insights into WAT browning (Review). Int J Mol Med 2021;47:71. [PMID: 33693956 DOI: 10.3892/ijmm.2021.4904] [Reference Citation Analysis]
119 Vilaca T, Schini M, Harnan S, Sutton A, Poku E, Allen IE, Cummings SR, Eastell R. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. Bone. 2020;137:115457. [PMID: 32480023 DOI: 10.1016/j.bone.2020.115457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
120 Shang W, Yang X, Ju X, Xie Y, Zhang Y, Lee W. Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii: Insulinotropic Peptide from Skin Secretions of Odorrana andersonii. J Pept Sci 2017;23:707-15. [DOI: 10.1002/psc.3017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
121 Khosla S, Samakkarnthai P, Monroe DG, Farr JN. Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus. Nat Rev Endocrinol 2021;17:685-97. [PMID: 34518671 DOI: 10.1038/s41574-021-00555-5] [Reference Citation Analysis]
122 Faraj M, Napoli N. The Impact of Diet on Bone and Fracture Risk in Diabetes. Curr Osteoporos Rep 2022. [PMID: 35201556 DOI: 10.1007/s11914-022-00725-y] [Reference Citation Analysis]
123 Andrade VFC, Besen D, Chula DC, Borba VZC, Dempster D, Moreira CA. Bone marrow adiposity in premenopausal women with type 2 diabetes with observations on peri-trabecular adipocytes. J Clin Endocrinol Metab 2021:dgab322. [PMID: 33974069 DOI: 10.1210/clinem/dgab322] [Reference Citation Analysis]
124 Londzin P, Kocik S, Kisiel-nawrot E, Janas A, Skoczyńska A, Krivošíková Z, Štefíková K, Gajdoš M, Cegieła U, Folwarczna J. Lack of berberine effect on bone mechanical properties in rats with experimentally induced diabetes. Biomedicine & Pharmacotherapy 2022;146:112562. [DOI: 10.1016/j.biopha.2021.112562] [Reference Citation Analysis]
125 Okano I, Salzmann SN, Jones C, Reisener MJ, Ortiz Miller C, Shirahata T, Shue J, Carrino JA, Sama AA, Cammisa FP, Girardi FP, Hughes AP. The effect of obesity, diabetes, and epidural steroid injection on regional volumetric bone mineral density measured by quantitative computed tomography in the lumbosacral spine. Eur Spine J 2021;30:13-21. [PMID: 33040205 DOI: 10.1007/s00586-020-06610-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Li Y, Fu H, Wang H, Luo S, Wang L, Chen J, Lu H. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway. Molecular and Cellular Endocrinology 2020;515:110921. [DOI: 10.1016/j.mce.2020.110921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
127 Jia T, Wang YN, Feng Y, Wang C, Zhang D, Xu X. Pharmic Activation of PKG2 Alleviates Diabetes-Induced Osteoblast Dysfunction by Suppressing PLCβ1-Ca2+-Mediated Endoplasmic Reticulum Stress. Oxid Med Cell Longev 2021;2021:5552530. [PMID: 34221234 DOI: 10.1155/2021/5552530] [Reference Citation Analysis]
128 Chen Y, Chen L, Huang R, Yang W, Chen S, Lin K, Liu J. Investigation for GSK3β expression in diabetic osteoporosis and negative osteogenic effects of GSK3β on bone marrow mesenchymal stem cells under a high glucose microenvironment. Biochem Biophys Res Commun 2021;534:727-33. [PMID: 33190828 DOI: 10.1016/j.bbrc.2020.11.010] [Reference Citation Analysis]
129 Jensen MH, Vestergaard P. Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures. Osteoporos Int 2019;30:1663-70. [DOI: 10.1007/s00198-019-05014-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
130 Colleluori G, Aguirre L, Dorin R, Robbins D, Blevins D, Barnouin Y, Chen R, Qualls C, Villareal DT, Armamento-Villareal R. Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover. Bone 2017;99:14-9. [PMID: 28323146 DOI: 10.1016/j.bone.2017.03.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
131 Yoon SH, Kim BR, Lee SY, Beom J, Choi JH, Lim JY. Influence of comorbidities on functional outcomes in patients with surgically treated fragility hip fractures: a retrospective cohort study. BMC Geriatr 2021;21:283. [PMID: 33910513 DOI: 10.1186/s12877-021-02227-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Hou Y, Cao X, Hu X, Li X, Shi X, Wang H, Peng C, Li J, Li J, Li Q, Wu C, Xiao X. CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss. Genes Dis 2018;5:290-9. [PMID: 30320193 DOI: 10.1016/j.gendis.2018.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
133 Paiva LA, Silva IS, Oliveira Júnior SA, Souza AS, Jacques COB. Analysis of high-intensity interval training on bone mineral density in an experimental model of type 2 diabetes. Acta Cir Bras 2022;37:e370207. [PMID: 35507971 DOI: 10.1590/acb370207] [Reference Citation Analysis]
134 Qu B, Gong K, Yang H, Li Y, Jiang T, Zeng Z, Cao Z, Pan X. SIRT1 suppresses high glucose and palmitate-induced osteoclast differentiation via deacetylating p66Shc. Molecular and Cellular Endocrinology 2018;474:97-104. [DOI: 10.1016/j.mce.2018.02.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
135 Nedeva IR, Vitale M, Elson A, Hoyland JA, Bella J. Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease. Front Cell Dev Biol 2021;9:641162. [PMID: 33912557 DOI: 10.3389/fcell.2021.641162] [Reference Citation Analysis]
136 Xu Y, Zhang L, Xu J, Li J, Wang H, He F. Strontium-incorporated titanium implant surfaces treated by hydrothermal treatment enhance rapid osseointegration in diabetes: A preclinical vivo experimental study. Clin Oral Implants Res 2021. [PMID: 34416034 DOI: 10.1111/clr.13837] [Reference Citation Analysis]
137 Kaur J, Khosla S, Farr JN. Effects of diabetes on osteocytes. Curr Opin Endocrinol Diabetes Obes 2022. [PMID: 35749726 DOI: 10.1097/MED.0000000000000733] [Reference Citation Analysis]
138 de Oliveira PGFP, de Melo Soares MS, Silveira E Souza AMM, Taba M Jr, Palioto DB, Messora MR, Ghiraldini B, Nunes FAS, de Souza SLS. Influence of nano-hydroxyapatite coating implants on gene expression of osteogenic markers and micro-CT parameters. An in vivo study in diabetic rats. J Biomed Mater Res A 2021;109:682-94. [PMID: 32608088 DOI: 10.1002/jbm.a.37052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
139 Haarhaus M, Evenepoel P; European Renal Osteodystrophy (EUROD) workgroup., Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA). Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int 2021;100:546-58. [PMID: 34102219 DOI: 10.1016/j.kint.2021.04.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Hidayat K, Fang QL, Shi BM, Qin LQ. Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. Osteoporos Int 2021;32:1693-704. [PMID: 33860816 DOI: 10.1007/s00198-021-05934-2] [Reference Citation Analysis]
141 Kim JH, Kim AR, Choi YH, Jang S, Woo GH, Cha JH, Bak EJ, Yoo YJ. Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis. PLoS One 2017;12:e0189702. [PMID: 29240821 DOI: 10.1371/journal.pone.0189702] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
142 Khosla S, Farr JN, Monroe DG. Cellular senescence and the skeleton: pathophysiology and therapeutic implications. J Clin Invest 2022;132:e154888. [PMID: 35104801 DOI: 10.1172/JCI154888] [Reference Citation Analysis]
143 Guja C, Guja L, Miulescu RD. Effect of type 2 diabetes medications on fracture risk. Ann Transl Med 2019;7:580. [PMID: 31807561 DOI: 10.21037/atm.2019.09.51] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
144 Jang M, Kim H, Lea S, Oh S, Kim JS, Oh B. Effect of duration of diabetes on bone mineral density: a population study on East Asian males. BMC EndocrDisord. 2018;18:61. [PMID: 30185190 DOI: 10.1186/s12902-018-0290-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
145 He Q, Yang J, Zhang G, Chen D, Zhang M, Pan Z, Wang Z, Su L, Zeng J, Wang B, Wang H, Chen P. Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation. J Ethnopharmacol 2021;273:113946. [PMID: 33647426 DOI: 10.1016/j.jep.2021.113946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Eckert AJ, Mader JK, Altmeier M, Mühldorfer S, Gillessen A, Dallmeier D, Shah VN, Heyer C, Hartmann B, Holl RW. Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry. J Diabetes Complications 2020;34:107664. [PMID: 32624333 DOI: 10.1016/j.jdiacomp.2020.107664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Pusztai A, Hamar A, Czókolyová M, Gulyás K, Horváth Á, Végh E, Pethő Z, Szamosi S, Balogh E, Bodnár N, Bodoki L, Szentpétery Á, Bhattoa HP, Kerekes G, Juhász B, Szekanecz É, Hodosi K, Domján A, Szántó S, Raterman HG, Lems WF, Szekanecz Z, Szűcs G. Associations of vascular and bone status in arthritis patients. Sci Rep 2021;11:19504. [PMID: 34593938 DOI: 10.1038/s41598-021-99071-9] [Reference Citation Analysis]
148 Mathiesen IH, Pressler T, Oturai P, Katzenstein TL, Skov M, Frikke-Schmidt R, Hitz MF. Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis. Int J Endocrinol 2018;2018:4803974. [PMID: 29780417 DOI: 10.1155/2018/4803974] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
149 Frølich J, Winkler LA, Abrahamsen B, Bilenberg N, Hermann AP, Støving RK. Assessment of fracture risk in women with eating disorders: The utility of dual-energy x-ray absorptiometry (DXA)-Clinical cohort study. Int J Eat Disord 2020;53:595-605. [PMID: 32048754 DOI: 10.1002/eat.23245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
150 Hamad AF, Yan L, Leslie WD, Morin SN, Walld R, Roos LL, Yang S, Lix LM. Association Between Parental Type 1 and Type 2 Diabetes Diagnosis and Major Osteoporotic Fracture Risk in Adult Offspring: A Population-Based Cohort Study. Can J Diabetes 2021:S1499-2671(21)00105-2. [PMID: 34053878 DOI: 10.1016/j.jcjd.2021.04.005] [Reference Citation Analysis]
151 Napoli N, Schwartz AV, Schafer AL, Vittinghoff E, Cawthon PM, Parimi N, Orwoll E, Strotmeyer ES, Hoffman AR, Barrett-connor E, Black DM; for the Osteoporotic Fractures in Men (MrOS) Study Research Group. Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study: DIABETES AND VERTEBRAL FRACTURE RISK. J Bone Miner Res 2018;33:63-9. [DOI: 10.1002/jbmr.3287] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 8.2] [Reference Citation Analysis]
152 Wang J, Yi P, Huang Y, Yu Q, Mei Y, Chen J, Feng Y, Zhang X. Quantitative evaluation of bone marrow fat content and unsaturated fatty index in young male soccer players using proton magnetic resonance spectroscopy (1H-MRS): a preliminary study. Quant Imaging Med Surg 2021;11:4275-86. [PMID: 34603983 DOI: 10.21037/qims-21-64] [Reference Citation Analysis]
153 Jia S, Gong H, Cen H, Shi P, Zhang R, Li Z, Bi X. Influence of non-enzymatic glycation on the mechanical properties of cortical bone. J Mech Behav Biomed Mater 2021;119:104553. [PMID: 33930651 DOI: 10.1016/j.jmbbm.2021.104553] [Reference Citation Analysis]
154 Couoh LR. Differences between biological and chronological age-at-death in human skeletal remains: A change of perspective: COUOH. Am J Phys Anthropol 2017;163:671-95. [DOI: 10.1002/ajpa.23236] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
155 Iacobini C, Fantauzzi CB, Pugliese G, Menini S. Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis. Int J Mol Sci 2017;18:E2481. [PMID: 29160796 DOI: 10.3390/ijms18112481] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
156 Hofbauer LC, Busse B, Eastell R, Ferrari S, Frost M, Müller R, Burden AM, Rivadeneira F, Napoli N, Rauner M. Bone fragility in diabetes: novel concepts and clinical implications. The Lancet Diabetes & Endocrinology 2022;10:207-20. [DOI: 10.1016/s2213-8587(21)00347-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
157 Russo V, Chen R, Armamento-Villareal R. Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review. Front Endocrinol (Lausanne) 2020;11:607240. [PMID: 33537005 DOI: 10.3389/fendo.2020.607240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Riddle RC, Clemens TL. Bone Cell Bioenergetics and Skeletal Energy Homeostasis. Physiol Rev 2017;97:667-98. [PMID: 28202599 DOI: 10.1152/physrev.00022.2016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
159 Sarodnik C, Bours SPG, Schaper NC, van den Bergh JP, van Geel TACM. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018;109:70-77. [PMID: 29452785 DOI: 10.1016/j.maturitas.2017.12.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
160 Troy KL, Davis IS, Tenforde AS. A Narrative Review of Metatarsal Bone Stress Injury in Athletic Populations: Etiology, Biomechanics, and Management. PM R 2021;13:1281-90. [PMID: 33155355 DOI: 10.1002/pmrj.12518] [Reference Citation Analysis]
161 Colangelo L, Biamonte F, Pepe J, Cipriani C, Minisola S. Understanding and managing secondary osteoporosis. Expert Rev Endocrinol Metab 2019;14:111-22. [PMID: 30735441 DOI: 10.1080/17446651.2019.1575727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
162 Gomes PS, Resende M, Fernandes MH. Doxycycline restores the impaired osteogenic commitment of diabetic-derived bone marrow mesenchymal stromal cells by increasing the canonical WNT signaling. Mol Cell Endocrinol 2020;518:110975. [PMID: 32758627 DOI: 10.1016/j.mce.2020.110975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Bondarenko LB. Diabetes and Collagen: Interrelations. Avicenna J Med Biochem 2019;7:64-71. [DOI: 10.34172/ajmb.2019.12] [Reference Citation Analysis]
164 Bhatti FUR, Dadwal UC, Valuch CR, Tewari NP, Awosanya OD, de Andrade Staut C, Sun S, Mendenhall SK, Perugini AJ 3rd, Nagaraj RU, Battina HL, Nazzal MK, Blosser RJ, Maupin KA, Childress PJ, Li J, Kacena MA. The effects of high fat diet, bone healing, and BMP-2 treatment on endothelial cell growth and function. Bone 2021;146:115883. [PMID: 33581374 DOI: 10.1016/j.bone.2021.115883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Charlier S, Vavanikunnel J, Becker C, Jick SS, Meier C, Meier CR. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study. J Clin Endocrinol Metab 2021;106:554-66. [PMID: 33141149 DOI: 10.1210/clinem/dgaa796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Conte C, Epstein S, Napoli N. Insulin resistance and bone: a biological partnership. Acta Diabetol 2018;55:305-14. [PMID: 29333578 DOI: 10.1007/s00592-018-1101-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
167 Cai TT, Li HQ, Jiang LL, Wang HY, Luo MH, Su XF, Ma JH. Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study. Biomed Res Int 2021;2021:3361309. [PMID: 34580638 DOI: 10.1155/2021/3361309] [Reference Citation Analysis]
168 Lee EJ, Na W, Kang MK, Kim YH, Kim DY, Oh H, Kim SI, Oh SY, Park S, Park K, Kang YH. Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Biomedicines 2021;9:648. [PMID: 34200167 DOI: 10.3390/biomedicines9060648] [Reference Citation Analysis]
169 Mantovani A, Sani E, Fassio A, Colecchia A, Viapiana O, Gatti D, Idolazzi L, Rossini M, Salvagno G, Lippi G, Zoppini G, Byrne C, Bonora E, Targher G. Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes. Diabetes & Metabolism 2019;45:347-55. [DOI: 10.1016/j.diabet.2018.10.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
170 Vescini F, Chiodini I, Falchetti A, Palermo A, Salcuni AS, Bonadonna S, De Geronimo V, Cesareo R, Giovanelli L, Brigo M, Bertoldo F, Scillitani A, Gennari L. Management of Osteoporosis in Men: A Narrative Review. Int J Mol Sci 2021;22:13640. [PMID: 34948434 DOI: 10.3390/ijms222413640] [Reference Citation Analysis]
171 Napoli N, Incalzi RA, De Gennaro G, Marcocci C, Marfella R, Papalia R, Purrello F, Ruggiero C, Tarantino U, Tramontana F, Conte C. Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT). Nutr Metab Cardiovasc Dis 2021;31:1375-90. [PMID: 33812734 DOI: 10.1016/j.numecd.2021.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Cai ZY, Yang B, Shi YX, Zhang WL, Liu F, Zhao W, Yang MW. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway. Biochem Biophys Res Commun 2018;503:428-35. [PMID: 29649480 DOI: 10.1016/j.bbrc.2018.04.052] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
173 Hills JM, Khan I, Archer KR, Sivaganesan A, Daryoush J, Hong DY, Dahir KM, Devin CJ, Stephens B. Metabolic and Endocrine Disorders in Pseudarthrosis. Clinical Spine Surgery: A Spine Publication 2019;32:E252-7. [DOI: 10.1097/bsd.0000000000000788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
174 Cooper ID, Brookler KH, Crofts CAP. Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas. Biomedicines 2021;9:1165. [PMID: 34572351 DOI: 10.3390/biomedicines9091165] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Xie B, Chen S, Xu Y, Han W, Hu R, Chen M, Zhang Y, Ding S. The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment. Front Pharmacol 2021;12:697442. [PMID: 34220521 DOI: 10.3389/fphar.2021.697442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Qian B, Chen Q, Li L, Yan C. Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials. Osteoporos Int 2020;31:2313-20. [DOI: 10.1007/s00198-020-05590-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Thong EP, Milat F, Enticott JC, Joham AE, Ebeling PR, Mishra GD, Teede HJ. The diabetes-fracture association in women with type 1 and type 2 diabetes is partially mediated by falls: a 15-year longitudinal study. Osteoporos Int 2021;32:1175-84. [PMID: 33411006 DOI: 10.1007/s00198-020-05771-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
178 Gomes GJ, da Silva MF, da Silva E, Del Carlo RJ, da Cunha DNQ, Carneiro-Junior MA, Prímola-Gomes TN, Natali AJ. Swimming Training Does Not Affect the Recovery of Femoral Midshaft Structural and Mechanical Properties in Growing Diabetic Rats Treated with Insulin. Life (Basel) 2021;11:786. [PMID: 34440530 DOI: 10.3390/life11080786] [Reference Citation Analysis]
179 Corrao G, Monzio Compagnoni M, Ronco R, Merlino L, Ciardullo S, Perseghin G, Banfi G. Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? Clin Orthop Relat Res 2020;478:992-1003. [PMID: 31842141 DOI: 10.1097/CORR.0000000000001089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
180 Takeno A, Kanazawa I, Tanaka KI, Notsu M, Kanasaki K, Oono T, Ogawa Y, Sugimoto T. High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation. Diabetol Int 2021;12:171-80. [PMID: 33786272 DOI: 10.1007/s13340-020-00463-5] [Reference Citation Analysis]
181 Ferrari S, Eastell R, Napoli N, Schwartz A, Hofbauer LC, Chines A, Wang A, Pannacciulli N, Cummings SR. Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension. Bone. 2020;134:115268. [PMID: 32058020 DOI: 10.1016/j.bone.2020.115268] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
182 Shah VN, Carpenter RD, Ferguson VL, Schwartz AV. Bone health in type 1 diabetes. CurrOpinEndocrinol Diabetes Obes. 2018;25:231-236. [PMID: 29794498 DOI: 10.1097/med.0000000000000421] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 8.3] [Reference Citation Analysis]
183 Huang Z, Pei X, Graves DT. The Interrelationship Between Diabetes, IL-17 and Bone Loss. Curr Osteoporos Rep 2020;18:23-31. [DOI: 10.1007/s11914-020-00559-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
184 Zhang L, Wu Y, Qiu L, Liu Y, Li Q. Elevated Levels of Serum β2-Glycoprotein I/Oxidized Low-Density Lipoprotein Complexes Are Associated with Cerebral Infarction in Patients with Type 2 Diabetes Mellitus. Med Sci Monit 2018;24:1232-40. [PMID: 29489742 DOI: 10.12659/msm.907078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Yavropoulou MP, Makras P. Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations. Maturitas 2021;147:19-25. [PMID: 33832643 DOI: 10.1016/j.maturitas.2021.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Napoli N, Pannacciulli N, Vittinghoff E, Crittenden D, Yun J, Wang A, Wagman R, Schwartz AV. Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial. Diabetes Metab Res Rev. 2018;34:e2991. [PMID: 29430796 DOI: 10.1002/dmrr.2991] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
187 Jing Y, Wang X, Yu J, Wang X, Zhou Y, Tao B, Sun L, Liu J, Zhao H. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus. J Diabetes 2020;12:426-37. [PMID: 31778286 DOI: 10.1111/1753-0407.13011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
188 Zeng Y, Liang H, Guo Y, Feng Y, Yao Q. Adiponectin regulates osteocytic MLO-Y4 cell apoptosis in a high-glucose environment through the AMPK/FoxO3a signaling pathway. J Cell Physiol 2021;236:7088-96. [PMID: 33792917 DOI: 10.1002/jcp.30381] [Reference Citation Analysis]
189 Mendoza FA, Le Roux M, Ahmed I. Primary osteoporosis in men: an unmet medical need. Fertil Steril 2019;112:791-8. [PMID: 31731933 DOI: 10.1016/j.fertnstert.2019.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
190 Langdahl BL, Silverman S, Fujiwara S, Saag K, Napoli N, Soen S, Enomoto H, Melby TE, Disch DP, Marin F, Krege JH. Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies. Bone 2018;116:58-66. [DOI: 10.1016/j.bone.2018.07.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
191 Wang C, Zhang T, Wang P, Liu X, Zheng L, Miao L, Zhou D, Zhang Y, Hu Y, Yin H, Jiang Q, Jin H, Sun J. Bone metabolic biomarker-based diagnosis of type 2 diabetes osteoporosis by support vector machine. Ann Transl Med 2021;9:316. [PMID: 33708943 DOI: 10.21037/atm-20-3388] [Reference Citation Analysis]
192 Ham JR, Choi RY, Lee HI, Lee MK. Methoxsalen and Bergapten Prevent Diabetes-Induced Osteoporosis by the Suppression of Osteoclastogenic Gene Expression in Mice. Int J Mol Sci 2019;20:E1298. [PMID: 30875838 DOI: 10.3390/ijms20061298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
193 Sánchez-de-Diego C, Artigas N, Pimenta-Lopes C, Valer JA, Torrejon B, Gama-Pérez P, Villena JA, Garcia-Roves PM, Rosa JL, Ventura F. Glucose Restriction Promotes Osteocyte Specification by Activating a PGC-1α-Dependent Transcriptional Program. iScience 2019;15:79-94. [PMID: 31039455 DOI: 10.1016/j.isci.2019.04.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
194 Acevedo C, Sylvia M, Schaible E, Graham JL, Stanhope KL, Metz LN, Gludovatz B, Schwartz AV, Ritchie RO, Alliston TN, Havel PJ, Fields AJ. Contributions of Material Properties and Structure to Increased Bone Fragility for a Given Bone Mass in the UCD-T2DM Rat Model of Type 2 Diabetes. J Bone Miner Res 2018;33:1066-75. [PMID: 29342321 DOI: 10.1002/jbmr.3393] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
195 Henderson S, Ibe I, Cahill S, Chung YH, Lee FY. Bone Quality and Fracture-Healing in Type-1 and Type-2 Diabetes Mellitus. J Bone Joint Surg Am 2019;101:1399-410. [PMID: 31393433 DOI: 10.2106/JBJS.18.01297] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
196 Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E. Higher dose but not low dose proton pump inhibitors are associated with increased risk of subsequent hip fractures after first hip fracture: A nationwide observational cohort study. Bone Rep 2019;10:100204. [PMID: 30993153 DOI: 10.1016/j.bonr.2019.100204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
197 Villaseñor A, Aedo-Martín D, Obeso D, Erjavec I, Rodríguez-Coira J, Buendía I, Ardura JA, Barbas C, Gortazar AR. Metabolomics reveals citric acid secretion in mechanically-stimulated osteocytes is inhibited by high glucose. Sci Rep 2019;9:2295. [PMID: 30783155 DOI: 10.1038/s41598-018-38154-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
198 Graumam RQ, Pinheiro MM, Nery LE, Castro CHM. Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity. Osteoporos Int 2018;29:1457-68. [PMID: 29564475 DOI: 10.1007/s00198-018-4483-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
199 Almutlaq N, Neyman A, DiMeglio LA. Are diabetes microvascular complications risk factors for fragility fracture? Curr Opin Endocrinol Diabetes Obes 2021;28:354-9. [PMID: 33989258 DOI: 10.1097/MED.0000000000000642] [Reference Citation Analysis]
200 Wang N, Xu P, Wu R, Wang X, Wang Y, Shou D, Zhang Y. Timosaponin BII improved osteoporosis caused by hyperglycemia through promoting autophagy of osteoblasts via suppressing the mTOR/NFκB signaling pathway. Free Radic Biol Med 2021;171:112-23. [PMID: 33992678 DOI: 10.1016/j.freeradbiomed.2021.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
201 Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, Marcocci C, Napoli N, Rizzoli R, Giustina A. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? Rev Endocr Metab Disord 2021;22:1201-18. [PMID: 34940947 DOI: 10.1007/s11154-021-09693-7] [Reference Citation Analysis]
202 Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases. Periodontol 2000 2020;82:214-24. [PMID: 31850631 DOI: 10.1111/prd.12318] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 16.5] [Reference Citation Analysis]
203 Adil M, Mansoori MN, Singh D, Kandhare AD, Sharma M. Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk. Biomedicine & Pharmacotherapy 2017;94:1010-9. [DOI: 10.1016/j.biopha.2017.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
204 Pozzilli P, Pieralice S. Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. Endocrinol Metab (Seoul) 2018;33:147-59. [PMID: 29947172 DOI: 10.3803/EnM.2018.33.2.147] [Cited by in Crossref: 24] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
205 Chen Y, Zhou Y, Lin J, Zhang S. Challenges to Improve Bone Healing Under Diabetic Conditions. Front Endocrinol 2022;13:861878. [DOI: 10.3389/fendo.2022.861878] [Reference Citation Analysis]
206 Milovanovic P, Stojanovic M, Antonijevic D, Cirovic A, Radenkovic M, Djuric M. "Dangerous duo": Chronic nicotine exposure intensifies diabetes mellitus-related deterioration in bone microstructure - An experimental study in rats. Life Sci 2018;212:102-8. [PMID: 30266406 DOI: 10.1016/j.lfs.2018.09.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
207 Pacicca DM, Brown T, Watkins D, Kover K, Yan Y, Prideaux M, Bonewald L. Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes. Sci Rep. 2019;9:17353. [PMID: 31757981 DOI: 10.1038/s41598-019-52224-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
208 de Waard EAC, Driessen JHM, de Jong JJA, van Geel TACM, Henry RMA, van Onzenoort HAW, Schram MT, Dagnelie PC, van der Kallen CJ, Sep SJS, Stehouwer CDA, Schaper NC, Koster A, Savelberg HHCM, Neef C, Geusens PPMM, de Vries F, van den Bergh JPW. The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht study. Bone. 2017;101:156-161. [PMID: 28487133 DOI: 10.1016/j.bone.2017.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
209 Karner CM, Long F. Wnt signaling and cellular metabolism in osteoblasts. Cell Mol Life Sci 2017;74:1649-57. [PMID: 27888287 DOI: 10.1007/s00018-016-2425-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 110] [Article Influence: 18.3] [Reference Citation Analysis]
210 Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, Eschweiler J, Maffulli N. Fragility Fractures: Risk Factors and Management in the Elderly. Medicina (Kaunas) 2021;57:1119. [PMID: 34684156 DOI: 10.3390/medicina57101119] [Reference Citation Analysis]
211 Cosso R, Falchetti A. Metabolic syndrome and fragility fracture risk. Minerva Obstet Gynecol 2021;73:744-53. [PMID: 34905879 DOI: 10.23736/S2724-606X.20.04689-4] [Reference Citation Analysis]
212 Rokidi S, Andrade VF, Borba V, Shane E, Cohen A, Zwerina J, Paschalis EP, Moreira CA. Bone tissue material composition is compromised in premenopausal women with Type 2 diabetes. Bone 2020;141:115634. [DOI: 10.1016/j.bone.2020.115634] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
213 Suppli MH, Munck Af Rosenschöld P, Pappot H, Engelholm SA. Diabetes increases the risk of serious adverse events after re-irradiation of the spine. Radiother Oncol 2019;136:130-5. [PMID: 31015114 DOI: 10.1016/j.radonc.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
214 Shen X, Shen X, Li B, Zhu W, Fu Y, Xu R, Du Y, Cheng J, Jiang H. Abnormal macrophage polarization impedes the healing of diabetes-associated tooth sockets. Bone 2021;143:115618. [PMID: 32858254 DOI: 10.1016/j.bone.2020.115618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
215 Na D, Cong M, Zhang-Xin W, Rong C, Qin-Yi W, Yang-Na O, Zhi-Feng S. Underdiagnosis and underreporting of vertebral fractures on chest radiographs in men aged over 50 years or postmenopausal women with and without type 2 diabetes mellitus: a retrospective cohort study. BMC Med Imaging 2022;22:81. [PMID: 35501729 DOI: 10.1186/s12880-022-00811-8] [Reference Citation Analysis]
216 Ballato E, Deepika FNU, Russo V, Fleires-gutiérrez A, Colleluori G, Fuenmayor V, Chen R, Villareal DT, Qualls C, Armamento-villareal R. One-Year Mean A1c of > 7% is Associated with Poor Bone Microarchitecture and Strength in Men with Type 2 Diabetes Mellitus. Calcif Tissue Int. [DOI: 10.1007/s00223-022-00993-x] [Reference Citation Analysis]
217 Zhang X, Xu Y, Li F, Chen M. Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus. Osteoporos Int 2022. [PMID: 35451624 DOI: 10.1007/s00198-022-06404-z] [Reference Citation Analysis]
218 Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C, Zeghbi Cochenski Borba V. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr 2018;10:25. [PMID: 29632617 DOI: 10.1186/s13098-018-0326-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
219 Hua Y, Bi R, Zhang Y, Xu L, Guo J, Li Y. Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture. PLoS One 2018;13:e0205503. [PMID: 30346963 DOI: 10.1371/journal.pone.0205503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
220 Jiang N, Xia W. Assessment of bone quality in patients with diabetes mellitus. Osteoporos Int. 2018;29:1721-1736. [PMID: 29736760 DOI: 10.1007/s00198-018-4532-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
221 Dias PC, Limirio PHJO, Linhares CRB, Bergamini ML, Rocha FS, Morais RB, Balbi APC, Hiraki KRN, Dechichi P. Hyperbaric Oxygen therapy effects on bone regeneration in Type 1 diabetes mellitus in rats. Connect Tissue Res. 2018;59:574-580. [PMID: 29378458 DOI: 10.1080/03008207.2018.1434166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
222 Garita B, Maligro J, Sadoughi S, Wu PH, Liebenberg E, Horvai A, Link TM, Kazakia GJ. Microstructural abnormalities are evident by histology but not HR-pQCT at the periosteal cortex of the human tibia under CVD and T2D conditions. Medicine in Novel Technology and Devices 2021;10:100062. [DOI: 10.1016/j.medntd.2021.100062] [Reference Citation Analysis]
223 Paschou SA, Vryonidou A. Diabetes mellitus and osteoporosis. Minerva Endocrinol 2019;44:333-5. [PMID: 31240900 DOI: 10.23736/S0391-1977.19.03040-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
224 Wang L, Zhao K, Zha X, Ran L, Su H, Yang Y, Shuang Q, Liu Y, Xu L, Blake GM, Cheng X, Engelke K, Vlug A. Hyperglycemia Is Not Associated With Higher Volumetric BMD in a Chinese Health Check-up Cohort. Front Endocrinol (Lausanne) 2021;12:794066. [PMID: 35046898 DOI: 10.3389/fendo.2021.794066] [Reference Citation Analysis]
225 Cirovic A, Vujacic M, Petrovic B, Cirovic A, Zivkovic V, Nikolic S, Djonic D, Bascarevic Z, Djuric M, Milovanovic P. Vascular Complications in Individuals with Type 2 Diabetes Mellitus Additionally Increase the Risk of Femoral Neck Fractures Due to Deteriorated Trabecular Microarchitecture. Calcif Tissue Int 2021. [PMID: 34302494 DOI: 10.1007/s00223-021-00894-5] [Reference Citation Analysis]
226 Hu Y, Li X, Yan X, Huang G, Dai R, Zhou Z. Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes. Diabetes Metab Res Rev 2021;37:e3390. [PMID: 32748546 DOI: 10.1002/dmrr.3390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
227 Lee RH, Sloane R, Pieper C, Lyles KW, Adler RA, Van Houtven C, LaFleur J, Colón-Emeric C. Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications. J Clin Endocrinol Metab 2018;103:281-7. [PMID: 29099931 DOI: 10.1210/jc.2017-01593] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
228 Muschitz C, Kautzky-Willer A, Rauner M, Winhöfer-Stöckl Y, Haschka J. [Diagnosis and management of patients with diabetes and co-existing osteoporosis (Update 2019) : Common guideline of the Autrian Society for Bone and Mineral Research and the Austrian Diabetes Society]. Wien Klin Wochenschr 2019;131:174-85. [PMID: 30980167 DOI: 10.1007/s00508-019-1462-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
229 Jing W, Feng L, Peng K, Zhang W, Wang B. Formononetin attenuates osteoclast differentiation and calcium loss by mediating transcription factor AP-1 in type I diabetic mice. J Biochem Mol Toxicol 2022;:e23042. [PMID: 35315182 DOI: 10.1002/jbt.23042] [Reference Citation Analysis]
230 Shao X, Yang Y, Tan Z, Ding Y, Luo E, Jing D, Cai J. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling. Am J Physiol Endocrinol Metab 2021;320:E951-66. [PMID: 33719588 DOI: 10.1152/ajpendo.00655.2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
231 Pal R, Bhadada SK. Bone health in diabetes: Indian perspective. Curr Opin Endocrinol Diabetes Obes 2021;28:383-9. [PMID: 33978603 DOI: 10.1097/MED.0000000000000640] [Reference Citation Analysis]
232 Sha NN, Zhang JL, Poon CC, Li WX, Li Y, Wang YF, Shi W, Lin FH, Lin WP, Wang YJ, Zhang Y. Differential responses of bone to angiotensin II and angiotensin(1-7): beneficial effects of ANG(1-7) on bone with exposure to high glucose. Am J Physiol Endocrinol Metab 2021;320:E55-70. [PMID: 33103451 DOI: 10.1152/ajpendo.00158.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Breuil V, Trojani MC, Ez-Zoubir A. Oxytocin and Bone: Review and Perspectives. Int J Mol Sci 2021;22:8551. [PMID: 34445256 DOI: 10.3390/ijms22168551] [Reference Citation Analysis]
234 Liu X, Tan N, Zhou Y, Wei H, Ren S, Yu F, Chen H, Jia C, Yang G, Song Y. Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus. Int J Nanomedicine 2017;12:7089-101. [PMID: 29026303 DOI: 10.2147/IJN.S124584] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
235 Rivoira M, Rodríguez V, Picotto G, Battaglino R, Tolosa de Talamoni N. Naringin prevents bone loss in a rat model of type 1 Diabetes mellitus. Archives of Biochemistry and Biophysics 2018;637:56-63. [DOI: 10.1016/j.abb.2017.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
236 Anagnostis P, Paschou SA, Gkekas NN, Artzouchaltzi A, Christou K, Stogiannou D, Vryonidou A, Potoupnis M, Goulis DG. Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review. Endocrine 2018;60:373-83. [DOI: 10.1007/s12020-018-1548-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
237 Zhang Y, Chen Q, Liang Y, Dong Y, Mo X, Zhang L, Zhang B. Insulin use and fracture risk in patients with type 2 diabetes: A meta-analysis of 138,690 patients. Exp Ther Med. 2019;17:3957-3964. [PMID: 31007738 DOI: 10.3892/etm.2019.7461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
238 Wang HJ, Giambini H, Chen JW, Wang QS, Hou HG, Luo SM, Chen JY, Zhuang TF, Chen YF, Wu TT, Zha ZG, Liu YJ, Zheng XF. Diabetes mellitus accelerates the progression of osteoarthritis in streptozotocin-induced diabetic mice by deteriorating bone microarchitecture, bone mineral composition, and bone strength of subchondral bone. Ann Transl Med 2021;9:768. [PMID: 34268381 DOI: 10.21037/atm-20-6797] [Reference Citation Analysis]
239 Wen Z, Ding N, Chen R, Liu S, Wang Q, Sheng Z, Liu H. Comparison of methods to improve fracture risk assessment in chinese diabetic postmenopausal women: a case-control study. Endocrine 2021;73:209-16. [PMID: 33932202 DOI: 10.1007/s12020-021-02724-y] [Reference Citation Analysis]
240 Momeni Z, Logan JE, Sigal RJ, Yardley JE. Can Resistance Exercise Be a Tool for Healthy Aging in Post-Menopausal Women with Type 1 Diabetes? Int J Environ Res Public Health 2021;18:8716. [PMID: 34444464 DOI: 10.3390/ijerph18168716] [Reference Citation Analysis]
241 Daniilopoulou I, Vlachou E, Lambrou GI, Ntikoudi A, Dokoutsidou E, Fasoi G, Govina O, Kavga A, Tsartsalis AN. The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review. Medicina 2022;58:224. [DOI: 10.3390/medicina58020224] [Reference Citation Analysis]
242 Park Y, Musson DS, Naot D, Cornish J. Cell–cell communication in bone development and whole-body homeostasis and pharmacological avenues for bone disorders. Current Opinion in Pharmacology 2017;34:21-35. [DOI: 10.1016/j.coph.2017.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
243 Rao P, Lou F, Luo D, Huang C, Huang K, Yao Z, Xiao J. Decreased autophagy impairs osteogenic differentiation of adipose-derived stem cells via Notch signaling in diabetic osteoporosis mice. Cell Signal 2021;87:110138. [PMID: 34461277 DOI: 10.1016/j.cellsig.2021.110138] [Reference Citation Analysis]
244 Leanza G, Maddaloni E, Pitocco D, Conte C, Palermo A, Maurizi AR, Pantano AL, Suraci C, Altomare M, Strollo R, Manfrini S, Pozzilli P, Schwartz AV, Napoli N. Risk factors for fragility fractures in type 1 diabetes. Bone. 2019;125:194-199. [PMID: 31059862 DOI: 10.1016/j.bone.2019.04.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
245 Yang C, Zheng Z, Younis MR, Dong C, Chen Y, Lei S, Zhang D, Wu J, Wu X, Lin J, Wang X, Huang P. 3D Printed Enzyme‐Functionalized Scaffold Facilitates Diabetic Bone Regeneration. Adv Funct Mater 2021;31:2101372. [DOI: 10.1002/adfm.202101372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
246 Johansson M, Ricci F, Di Martino G, Rogmark C, Sutton R, Hamrefors V, Melander O, Fedorowski A. Cardiovascular biomarkers predict fragility fractures in older adults. Heart 2019;105:449-54. [PMID: 30322844 DOI: 10.1136/heartjnl-2018-313741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
247 Ambrosi TH, Schulz TJ. The emerging role of bone marrow adipose tissue in bone health and dysfunction. J Mol Med (Berl) 2017;95:1291-301. [PMID: 29101431 DOI: 10.1007/s00109-017-1604-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
248 Zha K, An Z, Ge S, Cai J, Zhou Y, Ying R, Zhou J, Gu T, Guo H, Zhao Y, Wang N, Lu Y. FSH may mediate the association between HbA1c and bone turnover markers in postmenopausal women with type 2 diabetes. J Bone Miner Metab. [DOI: 10.1007/s00774-021-01301-7] [Reference Citation Analysis]
249 Colleluori G, Aguirre L, Napoli N, Qualls C, Villareal DT, Armamento-Villareal R. Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes. J Clin Endocrinol Metab 2021;106:e3058-68. [PMID: 33735389 DOI: 10.1210/clinem/dgab181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
250 Al Monaei K, Robert AA, Farghaly H, Al Rashidi D, Abdulathi M, Al Najimi R, Al Musalm M, Mamoun M, Ali N, Al Qahtani S, Al Dawish M. Assessment of risk factors for bone fractures in patients with type 2 diabetes mellitus: A study in Saudi Arabia. Diabetes Metab Syndr 2021;15:955-61. [PMID: 33940428 DOI: 10.1016/j.dsx.2021.04.008] [Reference Citation Analysis]
251 Jeddi S, Yousefzadeh N, Kashfi K, Ghasemi A. Role of nitric oxide in type 1 diabetes-induced osteoporosis. Biochem Pharmacol 2021;:114888. [PMID: 34968494 DOI: 10.1016/j.bcp.2021.114888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Xm S, Cc L, C L, Yf L, L C, Yz Z, Sj Y. TLR4 inhibition ameliorated glucolipotoxicity-induced differentiation suppression in osteoblasts via RIAM regulation of NF-κB nuclear translocation. Mol Cell Endocrinol 2021;543:111539. [PMID: 34929310 DOI: 10.1016/j.mce.2021.111539] [Reference Citation Analysis]
253 Huang T, Yu Z, Yu Q, Chen Y, Jiang Z, Wang Y, Yang G. Electrochemical deposition of lithium coating on titanium implant with enhanced early stage osseointegration. J Biomed Mater Res B Appl Biomater 2022. [PMID: 35604032 DOI: 10.1002/jbm.b.35085] [Reference Citation Analysis]
254 Teissier T, Temkin V, Pollak RD, Cox LS. Crosstalk Between Senescent Bone Cells and the Bone Tissue Microenvironment Influences Bone Fragility During Chronological Age and in Diabetes. Front Physiol 2022;13:812157. [DOI: 10.3389/fphys.2022.812157] [Reference Citation Analysis]
255 Kanazawa I, Tanaka KI, Takeo A, Notsu M, Miyake H, Sugimoto T. A scoring assessment tool for the risk of vertebral fractures in patients with type 2 diabetes mellitus. Bone 2019;122:38-44. [PMID: 30763635 DOI: 10.1016/j.bone.2019.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
256 Peng XY, Hu M, Liao F, Yang F, Ke QF, Guo YP, Zhu ZH. La-Doped mesoporous calcium silicate/chitosan scaffolds for bone tissue engineering. Biomater Sci 2019;7:1565-73. [PMID: 30688345 DOI: 10.1039/c8bm01498a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 6.3] [Reference Citation Analysis]
257 Nakamura M, Inaba M, Yamada S, Ozaki E, Maruo S, Okuno S, Imanishi Y, Kuriyama N, Watanabe Y, Emoto M, Motoyama K. Association of Decreased Handgrip Strength with Reduced Cortical Thickness in Japanese Female Patients with Type 2 Diabetes Mellitus. Sci Rep 2018;8:10767. [PMID: 30018407 DOI: 10.1038/s41598-018-29061-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
258 Sihota P, Yadav RN, Dhaliwal R, Bose JC, Dhiman V, Neradi D, Karn S, Sharma S, Aggarwal S, Goni VG, Mehandia V, Vashishth D, Bhadada SK, Kumar N. Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes. J Clin Endocrinol Metab 2021;106:e2271-89. [PMID: 33475711 DOI: 10.1210/clinem/dgab027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
259 Schousboe JT, Morin SN, Kline GA, Lix LM, Leslie WD. Differential risk of fracture attributable to type 2 diabetes mellitus according to skeletal site. Bone 2021;154:116220. [PMID: 34571204 DOI: 10.1016/j.bone.2021.116220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
260 Piccoli A, Cannata F, Strollo R, Pedone C, Leanza G, Russo F, Greto V, Isgrò C, Quattrocchi CC, Massaroni C, Silvestri S, Vadalà G, Bisogno T, Denaro V, Pozzilli P, Tang SY, Silva MJ, Conte C, Papalia R, Maccarrone M, Napoli N. Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes. J Bone Miner Res 2020;35:2415-22. [PMID: 32777114 DOI: 10.1002/jbmr.4153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
261 Wierzbicka E, Swiercz A, Pludowski P, Jaworski M, Szalecki M. Skeletal Status, Body Composition, and Glycaemic Control in Adolescents with Type 1 Diabetes Mellitus. J Diabetes Res 2018;2018:8121634. [PMID: 30250851 DOI: 10.1155/2018/8121634] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
262 Jia X, Liu L, Wang R, Liu X, Liu B, Ma N, Lu Q. Relationship of Two-Hour Plasma Glucose and Abdominal Visceral Fat with Bone Mineral Density and Bone Mineral Content in Women with Different Glucose Metabolism Status. Diabetes Metab Syndr Obes 2020;13:851-8. [PMID: 32256099 DOI: 10.2147/DMSO.S245096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
263 Xian T, Gan Y, Lu Y, Wang M, Yuan W, Zhou Y, Chen J, Wang K, Xiong S, Huang Q. Ameliorative effects of indomethacin at different concentrations on endothelial insulin resistance through two distinct pathways. Biomed Pharmacother 2018;106:1161-8. [PMID: 30119183 DOI: 10.1016/j.biopha.2018.07.069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
264 Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 2021; 12(6): 706-729 [PMID: 34168723 DOI: 10.4239/wjd.v12.i6.706] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Zhang J, Wang YN, Jia T, Huang H, Zhang D, Xu X. Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats. J Orthop Surg Res 2021;16:59. [PMID: 33446235 DOI: 10.1186/s13018-021-02210-1] [Reference Citation Analysis]
266 Zhang J, Zhang Y, Wang J, Yu F. Characteristics of bone turnover markers in women with gestational diabetes mellitus. Clin Biochem 2020;77:36-40. [PMID: 31899278 DOI: 10.1016/j.clinbiochem.2019.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Vilahur G, Nguyen PH, Badimon L. Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart. Cardiovasc Drugs Ther 2021. [PMID: 34251593 DOI: 10.1007/s10557-021-07208-9] [Reference Citation Analysis]
268 Shi T, Lu K, Shen S, Tang Q, Zhang K, Zhu X, Shi Y, Liu X, Teng H, Li C, Xue B, Jiang Q. Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model. Lipids Health Dis 2017;16:201. [PMID: 29029615 DOI: 10.1186/s12944-017-0592-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
269 Rharass T, Lucas S. High Glucose Level Impairs Human Mature Bone Marrow Adipocyte Function Through Increased ROS Production. Front Endocrinol (Lausanne) 2019;10:607. [PMID: 31551934 DOI: 10.3389/fendo.2019.00607] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
270 Hu XF, Feng YF, Xiang G, Lei W, Wang L. Lactic acid of PLGA coating promotes angiogenesis on the interface between porous titanium and diabetic bone. J Mater Chem B 2018;6:2274-88. [PMID: 32254567 DOI: 10.1039/c7tb03247a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
271 Londzin P, Kisiel-Nawrot E, Kocik S, Janas A, Trawczyński M, Cegieła U, Folwarczna J. Effects of diosgenin on the skeletal system in rats with experimental type 1 diabetes. Biomed Pharmacother 2020;129:110342. [PMID: 32554252 DOI: 10.1016/j.biopha.2020.110342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
272 Valentini A, Cianfarani MA, De Meo L, Morabito P, Romanello D, Tarantino U, Federici M, Bertoli A. FRAX tool in type 2 diabetic subjects: the use of HbA1c in estimating fracture risk. Acta Diabetol 2018;55:1043-50. [PMID: 29980834 DOI: 10.1007/s00592-018-1187-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
273 Pereira M, Gohin S, Roux JP, Fisher A, Cleasby ME, Mabilleau G, Chenu C. Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2017;8:327. [PMID: 29209277 DOI: 10.3389/fendo.2017.00327] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
274 Ferrari S. Diabetes and Bone. Calcif Tissue Int 2017;100:107-8. [PMID: 28180918 DOI: 10.1007/s00223-017-0234-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
275 Napoli N. Osteoporosis/bone fragility. JGG 2021;69:265-8. [DOI: 10.36150/2499-6564-n456] [Reference Citation Analysis]
276 Santopaolo M, Gu Y, Spinetti G, Madeddu P. Bone marrow fat: friend or foe in people with diabetes mellitus? Clin Sci (Lond) 2020;134:1031-48. [PMID: 32337536 DOI: 10.1042/CS20200220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
277 Liu C, Zhu R, Liu H, Li L, Chen B, Jia Q, Wang L, Ma R, Tian S, Wang M, Fu M, Niu J, Orekhov AN, Gao S, Zhang D, Zhao B. Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats. Front Pharmacol 2018;9:1239. [PMID: 30459613 DOI: 10.3389/fphar.2018.01239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
278 Hidayat K, Du X, Shi B. Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies. Osteoporos Int 2019;30:1923-40. [DOI: 10.1007/s00198-019-04968-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
279 Sanz-Nogués C, Mustafa M, Burke H, O'Brien T, Coleman CM. Knowledge, Perceptions and Concerns of Diabetes -Associated Complications Among Individuals Living with Type 1 and Type 2 Diabetes Mellitus. Healthcare (Basel) 2020;8:E25. [PMID: 32019118 DOI: 10.3390/healthcare8010025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Tencerova M, Frost M, Figeac F, Nielsen TK, Ali D, Lauterlein JL, Andersen TL, Haakonsson AK, Rauch A, Madsen JS, Ejersted C, Højlund K, Kassem M. Obesity-Associated Hypermetabolism and Accelerated Senescence of Bone Marrow Stromal Stem Cells Suggest a Potential Mechanism for Bone Fragility. Cell Rep 2019;27:2050-2062.e6. [PMID: 31091445 DOI: 10.1016/j.celrep.2019.04.066] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
281 Li X, Li T, Cheng Y, Lu Y, Xue M, Xu L, Liu X, Yu X, Sun B, Chen L. Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta-analysis. Diabetes Metab Res Rev. 2019;e3170. [PMID: 30983141 DOI: 10.1002/dmrr.3170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
282 Langdahl JH, Frederiksen AL, Hansen SJ, Andersen PH, Yderstraede KB, Dunø M, Vissing J, Frost M. Mitochondrial Point Mutation m.3243A>G Associates With Lower Bone Mineral Density, Thinner Cortices, and Reduced Bone Strength: A Case-Control Study: M.3243A>G AND LOWER BMD, THINNER CORTICES, AND REDUCED BONE STRENGTH. J Bone Miner Res 2017;32:2041-8. [DOI: 10.1002/jbmr.3193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
283 de Paula FJA, Rosen CJ. Structure and Function of Bone Marrow Adipocytes. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 315-49. [DOI: 10.1002/cphy.c170010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
284 Leanza G, Fontana F, Lee SY, Remedi MS, Schott C, Ferron M, Hamilton-Hall M, Alippe Y, Strollo R, Napoli N, Civitelli R. Gain-of-Function Lrp5 Mutation Improves Bone Mass and Strength and Delays Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes. J Bone Miner Res 2021;36:1403-15. [PMID: 33831261 DOI: 10.1002/jbmr.4303] [Reference Citation Analysis]
285 Ávila-Rubio V, García-Fontana B, Novo-Rodríguez C, Cantero-Hinojosa J, Reyes-García R, Muñoz-Torres M. Higher Levels of Serum 25-Hydroxyvitamin D Are Related to Improved Glucose Homeostasis in Women with Postmenopausal Osteoporosis. J Womens Health (Larchmt) 2018;27:1007-15. [PMID: 29874115 DOI: 10.1089/jwh.2017.6806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
286 Zhang ZD, Ren H, Wang WX, Shen GY, Huang JJ, Zhan MQ, Tang JJ, Yu X, Zhang YZ, Liang, Yang ZD, Jiang XB. IGF-1R/β-catenin signaling axis is involved in type 2 diabetic osteoporosis. J Zhejiang Univ Sci B 2019;20:838-48. [PMID: 31489803 DOI: 10.1631/jzus.B1800648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
287 Tian L, Yu X. Fat, Sugar, and Bone Health: A Complex Relationship. Nutrients 2017;9:E506. [PMID: 28513571 DOI: 10.3390/nu9050506] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
288 Maamar El Asri M, Pariente Rodrigo E, Díaz-Salazar de la Flor S, Pini Valdivieso S, Ramos Barrón MC, Olmos Martínez JM, Hernández Hernández JL. Trabecular bone score and 25-hydroxyvitamin D levels in microvascular complications of type 2 diabetes mellitus. Med Clin (Barc) 2021:S0025-7753(21)00329-8. [PMID: 34238580 DOI: 10.1016/j.medcli.2021.04.027] [Reference Citation Analysis]
289 Lems WF. Is Fragility Fracture a Strong Risk Factor for a Cardiovascular Event in Rheumatoid Arthritis? The Challenge of Dealing with Multiple Comorbidities. J Rheumatol 2017;44:545-6. [PMID: 28461515 DOI: 10.3899/jrheum.170202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
290 Shah M, Appuswamy AV, Rao SD, Dhaliwal R. Treatment of bone fragility in patients with diabetes: antiresorptive versus anabolic? Curr Opin Endocrinol Diabetes Obes 2021;28:377-82. [PMID: 34010225 DOI: 10.1097/MED.0000000000000645] [Reference Citation Analysis]
291 Zheng HX, Chen J, Zu YX, Wang EZ, Qi SS. Chondroitin Sulfate Prevents STZ Induced Diabetic Osteoporosis through Decreasing Blood Glucose, AntiOxidative Stress, Anti-Inflammation and OPG/RANKL Expression Regulation. Int J Mol Sci 2020;21:E5303. [PMID: 32722636 DOI: 10.3390/ijms21155303] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
292 Rhee CM, Kovesdy CP, You AS, Sim JJ, Soohoo M, Streja E, Molnar MZ, Amin AN, Abbott K, Nguyen DV, Kalantar-Zadeh K. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis. Am J Kidney Dis 2018;72:701-10. [PMID: 30037725 DOI: 10.1053/j.ajkd.2018.04.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
293 Sherk VD, Schauer I, Shah VN. Update on the Acute Effects of Glucose, Insulin, and Incretins on Bone Turnover In Vivo. Curr Osteoporos Rep 2020;18:371-7. [PMID: 32504189 DOI: 10.1007/s11914-020-00598-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Palermo A, D'Onofrio L, Buzzetti R, Manfrini S, Napoli N. Pathophysiology of Bone Fragility in Patients with Diabetes. Calcif Tissue Int 2017;100:122-32. [PMID: 28180919 DOI: 10.1007/s00223-016-0226-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
295 Guerrero-Pérez F, Casajoana A, Gómez-Vaquero C, Virgili N, López-Urdiales R, Hernández-Montoliu L, Pujol-Gebelli J, Osorio J, Alves C, Perez-Maraver M, Pellitero S, Vidal-Alabró A, Fernández-Veledo S, Vendrell J, Vilarrasa N. Changes in Bone Mineral Density in Patients with Type 2 Diabetes After Different Bariatric Surgery Procedures and the Role of Gastrointestinal Hormones. Obes Surg 2020;30:180-8. [PMID: 31420830 DOI: 10.1007/s11695-019-04127-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
296 Wang H, Zheng X, Zhang Y, Huang J, Zhou W, Li X, Tian H, Wang B, Xing D, Fu W, Chen T, Wang X, Zhang X, Wu A. The endocrine role of bone: Novel functions of bone-derived cytokines. Biochem Pharmacol 2021;183:114308. [PMID: 33137323 DOI: 10.1016/j.bcp.2020.114308] [Reference Citation Analysis]
297 Chiodini I, Catalano A, Gennari L, Gaudio A. Osteoporosis and Fragility Fractures in Type 2 Diabetes. J Diabetes Res 2020;2020:9342696. [PMID: 32733970 DOI: 10.1155/2020/9342696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect 2019;8:R55-70. [PMID: 30772871 DOI: 10.1530/EC-18-0456] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 9.3] [Reference Citation Analysis]
299 Liu S, Wang W, Yin L, Zhu Y. Influence of Apelin-13 on osteoporosis in Type-2 diabetes mellitus: A clinical study. Pak J Med Sci 2018;34:159-63. [PMID: 29643899 DOI: 10.12669/pjms.341.14135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
300 Anna UM, Maria S, Kerstin B. Comparison of quantitative ultrasound of calcaneus and dual energy X-ray absorptiometry in measuring bone density and predicting fractures in patients with diabetic polyneuropathy: A prospective cohort study. Diabetes Res Clin Pract 2021;180:109064. [PMID: 34562510 DOI: 10.1016/j.diabres.2021.109064] [Reference Citation Analysis]
301 Chen Y, Ma B, Wang X, Zha X, Sheng C, Yang P, Qu S. Potential Functions of the BMP Family in Bone, Obesity, and Glucose Metabolism. J Diabetes Res 2021;2021:6707464. [PMID: 34258293 DOI: 10.1155/2021/6707464] [Reference Citation Analysis]
302 Lasschuit JWJ, Greenfield JR, Tonks KTT. Contribution of peripheral neuropathy to poor bone health in the feet of people with type 2 diabetes mellitus. Acta Diabetol 2022;59:217-24. [PMID: 34568958 DOI: 10.1007/s00592-021-01803-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Cheng K, Guo Q, Yang W, Wang Y, Sun Z, Wu H. Mapping Knowledge Landscapes and Emerging Trends of the Links Between Bone Metabolism and Diabetes Mellitus: A Bibliometric Analysis From 2000 to 2021. Front Public Health 2022;10:918483. [DOI: 10.3389/fpubh.2022.918483] [Reference Citation Analysis]
304 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
305 Gao Y, Chai F. Risk of non-vertebral fractures in men with type 2 diabetes: A systematic review and meta-analysis of cohort studies. Exp Gerontol 2021;150:111378. [PMID: 33905874 DOI: 10.1016/j.exger.2021.111378] [Reference Citation Analysis]
306 Li X, Li B, Shi Y, Wang C, Ye L. Targeting reactive oxygen species in stem cells for bone therapy. Drug Discov Today 2021;26:1226-44. [PMID: 33684524 DOI: 10.1016/j.drudis.2021.03.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Szekanecz Z, Raterman HG, Pethő Z, Lems WF. Common mechanisms and holistic care in atherosclerosis and osteoporosis. Arthritis Res Ther 2019;21:15. [PMID: 30630495 DOI: 10.1186/s13075-018-1805-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
308 Portillo-Sanchez P, Bril F, Lomonaco R, Barb D, Orsak B, Bruder JM, Cusi K. Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial. J Diabetes. 2018;. [PMID: 30073778 DOI: 10.1111/1753-0407.12833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
309 Yang J, Ueharu H, Mishina Y. Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis. Bone 2020;138:115467. [PMID: 32512164 DOI: 10.1016/j.bone.2020.115467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
310 Gil-Díaz MC, Raynor J, O'Brien KO, Schwartz GJ, Weber DR. Systematic review: associations of calcium intake, vitamin D intake, and physical activity with skeletal outcomes in people with Type 1 diabetes mellitus. Acta Diabetol 2019;56:1091-102. [PMID: 30989378 DOI: 10.1007/s00592-019-01334-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
311 Rozenberg S, Bruyère O, Bergmann P, Cavalier E, Gielen E, Goemaere S, Kaufman JM, Lapauw B, Laurent MR, De Schepper J, Body JJ. How to manage osteoporosis before the age of 50. Maturitas 2020;138:14-25. [PMID: 32631584 DOI: 10.1016/j.maturitas.2020.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
312 Jiajue R, Qi X, Jiang Y, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study. Calcif Tissue Int 2019;105:466-75. [DOI: 10.1007/s00223-019-00598-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
313 Beeve AT, Brazill JM, Scheller EL. Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes. Curr Osteoporos Rep 2019;17:256-69. [PMID: 31392667 DOI: 10.1007/s11914-019-00528-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
314 Yang J, Chen S, Zong Z, Yang L, Liu D, Bao Q, Du W. The increase in bone resorption in early-stage type I diabetic mice is induced by RANKL secreted by increased bone marrow adipocytes. Biochem Biophys Res Commun. 2020;525:433-439. [PMID: 32102755 DOI: 10.1016/j.bbrc.2020.02.079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
315 Boregowda SV, Ghoshal S, Booker CN, Krishnappa V, Chakraborty A, Phinney DG. IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet-Induced Skeletal Involution. Stem Cells 2017;35:1973-83. [PMID: 28577302 DOI: 10.1002/stem.2645] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
316 Turcotte AF, Kukuljan S, Dalla Via J, Gagnon C, Abbott G, Daly RM. Changes in spinal bone density, back muscle size, and visceral adipose tissue and their interaction following a multi-component exercise program in older men: secondary analysis of an 18-month randomized controlled trial. Osteoporos Int 2020;31:2025-35. [PMID: 32500299 DOI: 10.1007/s00198-020-05484-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
317 Purnamasari D, Puspitasari MD, Setiyohadi B, Nugroho P, Isbagio H. Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study. BMC Endocr Disord. 2017;17:72. [PMID: 29187183 DOI: 10.1186/s12902-017-0224-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
318 Shao J, Liu S, Zheng X, Chen J, Li L, Zhu Z. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway. Biofactors 2021;47:80-92. [PMID: 33233028 DOI: 10.1002/biof.1692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
319 Wen Y, Li H, Zhang X, Liu P, Ma J, Zhang L, Zhang K, Song L. Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population. Front Endocrinol (Lausanne) 2021;12:531904. [PMID: 34054717 DOI: 10.3389/fendo.2021.531904] [Reference Citation Analysis]
320 Xu H, Wang Z, Li X, Fan M, Bao C, Yang R, Song F, Xu W, Qi X. Osteoporosis and Osteopenia Among Patients With Type 2 Diabetes Aged ≥50: Role of Sex and Clinical Characteristics. Journal of Clinical Densitometry 2020;23:29-36. [DOI: 10.1016/j.jocd.2019.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
321 Chiodini I, Gaudio A, Palermo A, Napoli N, Vescini F, Falchetti A, Merlotti D, Eller-Vainicher C, Carnevale V, Scillitani A, Pugliese G, Rendina D, Salcuni A, Bertoldo F, Gonnelli S, Nuti R, Toscano V, Triggiani V, Cenci S, Gennari L. Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel. Nutr Metab Cardiovasc Dis 2021;31:2210-33. [PMID: 34059385 DOI: 10.1016/j.numecd.2021.04.014] [Reference Citation Analysis]
322 Gomes GJ, Carlo RJD, Silva MFD, Cunha DNQD, Silva ED, Silva KAD, Carneiro-Junior MA, Prímola-Gomes TN, Natali AJ. Swimming training potentiates the recovery of femoral neck strength in young diabetic rats under insulin therapy. Clinics (Sao Paulo) 2019;74:e829. [PMID: 31038563 DOI: 10.6061/clinics/2019/e829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
323 Ojala R, Motiani KK, Ivaska KK, Arponen M, Eskelinen JJ, Virtanen KA, Löyttyniemi E, Heiskanen MA, U-Din M, Nuutila P, Kalliokoski KK, Hannukainen JC. Bone Marrow Metabolism Is Impaired in Insulin Resistance and Improves After Exercise Training. J Clin Endocrinol Metab 2020;105:dgaa516. [PMID: 32785654 DOI: 10.1210/clinem/dgaa516] [Reference Citation Analysis]
324 Grillari J, Mäkitie RE, Kocijan R, Haschka J, Vázquez DC, Semmelrock E, Hackl M. Circulating miRNAs in bone health and disease. Bone 2021;145:115787. [PMID: 33301964 DOI: 10.1016/j.bone.2020.115787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
325 Samakkarnthai P, Sfeir JG, Atkinson EJ, Achenbach SJ, Wennberg PW, Dyck PJ, Tweed AJ, Volkman TL, Amin S, Farr JN, Vella A, Drake MT, Khosla S. Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2020;105. [PMID: 32556277 DOI: 10.1210/clinem/dgaa388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
326 Napoli N, Conte C, Pedone C, Strotmeyer ES, Barbour KE, Black DM, Samelson EJ, Schwartz AV. Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults. J Clin Endocrinol Metab. 2019;104:3303-3310. [PMID: 30802282 DOI: 10.1210/jc.2018-02539] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
327 Mabilleau G, Gobron B, Bouvard B, Chappard D. Incretin-based therapy for the treatment of bone fragility in diabetes mellitus. Peptides 2018;100:108-13. [PMID: 29412811 DOI: 10.1016/j.peptides.2017.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
328 Castellano E, Attanasio R, Boriano A, Borretta V, Tassone F, Borretta G. Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal Experience. Front Endocrinol (Lausanne) 2021;12:665984. [PMID: 33953702 DOI: 10.3389/fendo.2021.665984] [Reference Citation Analysis]
329 Aparisi Gómez MP, Ayuso Benavent C, Simoni P, Aparisi F, Guglielmi G, Bazzocchi A. Fat and bone: the multiperspective analysis of a close relationship. Quant Imaging Med Surg 2020;10:1614-35. [PMID: 32742956 DOI: 10.21037/qims.2020.01.11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
330 Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management. J Clin Endocrinol Metab. 2017;102:3621-3634. [PMID: 28938433 DOI: 10.1210/jc.2017-00042] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 12.4] [Reference Citation Analysis]
331 Sihota P, Pal R, Yadav RN, Neradi D, Karn S, Goni VG, Sharma S, Mehandia V, Bhadada SK, Kumar N, Rao SD. Can fingernail quality predict bone damage in Type 2 diabetes mellitus? a pilot study. PLoS One 2021;16:e0257955. [PMID: 34591909 DOI: 10.1371/journal.pone.0257955] [Reference Citation Analysis]
332 Bezerra Melo KC, Alves dos Santos G, de Souza Araujo F, Moreira SR. Detraining period of the PILATES method on functional capacity of elderly women with type 2 diabetes: A randomized clinical trial. Journal of Bodywork and Movement Therapies 2022. [DOI: 10.1016/j.jbmt.2022.03.012] [Reference Citation Analysis]
333 Ha M, Chen J, Zhang X, Yang H, Liu C. Relationships of social support, health-promoting lifestyles, glycemic control, and bone turnover among adults with type 2 diabetes. Jpn J Nurs Sci 2020;17:e12280. [PMID: 31286684 DOI: 10.1111/jjns.12280] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
334 Mishra S, Nyomba BLG. Estrogen Deficiency Plus Type 1 Diabetes: A Double-Dip for Bone Loss. Endocrinology 2017;158:2066-7. [PMID: 28881867 DOI: 10.1210/en.2017-00438] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
335 Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P. The impact of type 2 diabetes on the development of tendinopathy. Diabetes Metab Res Rev 2021;37:e3417. [PMID: 33156563 DOI: 10.1002/dmrr.3417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
336 Farooqui KJ, Mithal A, Kerwen AK, Chandran M. Type 2 diabetes and bone fragility- An under-recognized association. Diabetes Metab Syndr 2021;15:927-35. [PMID: 33932745 DOI: 10.1016/j.dsx.2021.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Jiating L, Buyun J, Yinchang Z. Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes. Biomed Res Int 2019;2019:9203934. [PMID: 31886264 DOI: 10.1155/2019/9203934] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
338 Roh JG, Yoon JS, Park KJ, Lim JS, Lee HS, Hwang JS. Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes. Ann Pediatr Endocrinol Metab 2018;23:136-40. [PMID: 30286569 DOI: 10.6065/apem.2018.23.3.136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
339 Liu J, Yu D, Xu M, Feng R, Sun Y, Yin X, Lai H, Wang C, Liu J. β-Cell function is associated with osteosarcopenia in middle-aged and older nonobese patients with type 2 diabetes: A cross-sectional study. Open Med (Wars) 2021;16:1583-90. [PMID: 34722893 DOI: 10.1515/med-2021-0376] [Reference Citation Analysis]
340 Lee WC, Ji X, Nissim I, Long F. Malic Enzyme Couples Mitochondria with Aerobic Glycolysis in Osteoblasts. Cell Rep 2020;32:108108. [PMID: 32905773 DOI: 10.1016/j.celrep.2020.108108] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
341 Thayakaran R, Perrins M, Gokhale KM, Kumaran S, Narendran P, Price MJ, Nirantharakumar K, Toulis KA. Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis. Diabet Med 2019;36:1013-9. [PMID: 30848519 DOI: 10.1111/dme.13945] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
342 Ye J, Huang B, Gong P. Nerve growth factor-chondroitin sulfate/hydroxyapatite-coating composite implant induces early osseointegration and nerve regeneration of peri-implant tissues in Beagle dogs. J Orthop Surg Res 2021;16:51. [PMID: 33436038 DOI: 10.1186/s13018-020-02177-5] [Reference Citation Analysis]
343 Fiani B, Newhouse A, Sarhadi KJ, Arshad M, Soula M, Cathel A. Special Considerations to Improve Clinical Outcomes in Patients with Osteoporosis Undergoing Spine Surgery. Int J Spine Surg 2021;15:386-401. [PMID: 33900998 DOI: 10.14444/8050] [Reference Citation Analysis]
344 Mieczkowska A, Millar P, Chappard D, Gault VA, Mabilleau G. Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model. Calcif Tissue Int 2020;107:281-93. [PMID: 32642787 DOI: 10.1007/s00223-020-00720-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
345 Wang N, Zhang M, Ji J, Li D, Hu L, Meng J, Yu B. Type 2 diabetes mellitus and the risk of hip and vertebral fractures: a systematic review and meta-analysis of cohort studies. Int J Diabetes Dev Ctries 2022;42:29-39. [DOI: 10.1007/s13410-021-00973-1] [Reference Citation Analysis]
346 Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, Hirakata H, Tsuruya K, Nakano T, Kitazono T. Malnutrition-Inflammation Complex Syndrome (MICS) and Bone Fractures and Cardiovascular Events in Patients Undergoing Hemodialysis: The Q-Cohort Study. Kidney Medicine 2022. [DOI: 10.1016/j.xkme.2022.100408] [Reference Citation Analysis]
347 Jia S, Gong H, Zhang Y, Liu H, Cen H, Zhang R, Fan Y. Prediction of Femoral Strength Based on Bone Density and Biochemical Markers in Elderly Men With Type 2 Diabetes Mellitus. Front Bioeng Biotechnol 2022;10:855364. [DOI: 10.3389/fbioe.2022.855364] [Reference Citation Analysis]
348 García Martín A, de la Higuera López-Frías M, Cortés Berdonces M, Jodar Gimeno E, Ávila Rubio V, Alhambra MR, Muñoz Torres M. New technologies in the evaluation of bone fragility and its application in Endocrinology. Endocrinol Diabetes Nutr (Engl Ed) 2020;67:602-10. [PMID: 32439320 DOI: 10.1016/j.endinu.2020.01.005] [Reference Citation Analysis]
349 Zhang Q, Greenbaum J, Shen H, Zhao LJ, Zhang WD, Sun CQ, Deng HW. Detecting causal relationship between metabolic traits and osteoporosis using multivariable Mendelian randomization. Osteoporos Int 2021;32:715-25. [PMID: 32970198 DOI: 10.1007/s00198-020-05640-5] [Reference Citation Analysis]
350 Neumiller JJ, Alicic RZ, Tuttle KR. Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease. J Am Soc Nephrol 2017;28:2263-74. [PMID: 28465376 DOI: 10.1681/ASN.2016121372] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
351 Elefteriou F. Impact of the Autonomic Nervous System on the Skeleton. Physiol Rev 2018;98:1083-112. [PMID: 29717928 DOI: 10.1152/physrev.00014.2017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
352 Liu P, Wang W, Li Z, Li Y, Yu X, Tu J, Zhang Z, Czuczejko J. Ferroptosis: A New Regulatory Mechanism in Osteoporosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-10. [DOI: 10.1155/2022/2634431] [Reference Citation Analysis]
353 Al-Hamed FS, Mahri M, Al-Waeli H, Torres J, Badran Z, Tamimi F. Regenerative Effect of Platelet Concentrates in Oral and Craniofacial Regeneration. Front Cardiovasc Med 2019;6:126. [PMID: 31552270 DOI: 10.3389/fcvm.2019.00126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
354 Zhang L, Wang Q, Su H, Cheng J. Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts. J Biosci Bioeng 2021;131:671-8. [PMID: 33849774 DOI: 10.1016/j.jbiosc.2021.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
355 Lu CF, Liu WS, Huang HY, Ge XQ, Hua LY, Wang XQ, Su JB. The Positive Relationship Between the Low-Density Lipoprotein Cholesterol/Apoprotein B Ratio and Bone Turnover Markers in Patients With Type 2 Diabetes. Front Endocrinol (Lausanne) 2022;13:903336. [PMID: 35757416 DOI: 10.3389/fendo.2022.903336] [Reference Citation Analysis]
356 Giustina A, Bouillon R, Binkley N, Sempos C, Adler RA, Bollerslev J, Dawson-Hughes B, Ebeling PR, Feldman D, Heijboer A, Jones G, Kovacs CS, Lazaretti-Castro M, Lips P, Marcocci C, Minisola S, Napoli N, Rizzoli R, Scragg R, White JH, Formenti AM, Bilezikian JP. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus 2020;4:e10417. [PMID: 33354643 DOI: 10.1002/jbm4.10417] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
357 Usala RL, Fernandez SJ, Mete M, Shara NM, Verbalis JG. Hyponatremia Is Associated With Increased Osteoporosis and Bone Fractures in Patients With Diabetes With Matched Glycemic Control. J Endocr Soc 2019;3:411-26. [PMID: 30746503 DOI: 10.1210/js.2018-00320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Chen X, Yang K, Jin X, Meng Z, Liu B, Yu H, Lu P, Wang K, Fan Z, Tang Z, Zhang F, Liu C. Bone Autophagy: A Potential Way of Exercise-Mediated Meg3/P62/Runx2 Pathway to Regulate Bone Formation in T2DM Mice. Diabetes Metab Syndr Obes 2021;14:2753-64. [PMID: 34168475 DOI: 10.2147/DMSO.S299744] [Reference Citation Analysis]
359 Hu XF, Wang L, Lu YZ, Xiang G, Wu ZX, Yan YB, Zhang Y, Zhao X, Zang Y, Shi L, Lei W, Feng YF. Adiponectin improves the osteointegration of titanium implant under diabetic conditions by reversing mitochondrial dysfunction via the AMPK pathway in vivo and in vitro. Acta Biomater 2017;61:233-48. [PMID: 28624657 DOI: 10.1016/j.actbio.2017.06.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
360 Djukic K, Miladinovic-radmilovic N, Draskovic M, Djuric M. Morphological appearance of muscle attachment sites on lower limbs: Horse riders versus agricultural population. Int J Osteoarchaeol 2018;28:656-68. [DOI: 10.1002/oa.2680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
361 de Paiva Gonçalves V, Cabrera-Ortega AA, Carvalho JS, Ramadan D, Spolidorio LC. Physiological testosterone replacement effects on male aged rats with orchiectomy-induced osteoporosis in advanced stage: a tomographic and biomechanical pilot study. Aging Male 2021;24:139-47. [PMID: 34647515 DOI: 10.1080/13685538.2021.1990256] [Reference Citation Analysis]
362 Casimiro I, Sam S, Brady MJ. Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones. Physiol Rep 2019;7:e14111. [PMID: 31134746 DOI: 10.14814/phy2.14111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
363 Ha J, Jeong C, Han KD, Lim Y, Kim MK, Kwon HS, Song KH, Kang MI, Baek KH. Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data. Osteoporos Int 2021. [PMID: 34333678 DOI: 10.1007/s00198-021-06032-z] [Reference Citation Analysis]
364 Zoabi H, Nemcovsky CE, Bender O, Moses O, Weinreb M. Accelerated degradation of collagen membranes in type 1 diabetic rats is associated with increased expression and production of several inflammatory molecules. J Periodontol 2020;91:1348-56. [PMID: 32056217 DOI: 10.1002/JPER.19-0503] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
365 Capozzi A, Scambia G, Migliaccio S, Lello S. Role of vitamin K2 in bone metabolism: a point of view and a short reappraisal of the literature. Gynecol Endocrinol 2020;36:285-8. [PMID: 31711322 DOI: 10.1080/09513590.2019.1689554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
366 Yang Y, Lin Y, Wang M, Yuan K, Wang Q, Mu P, Du J, Yu Z, Yang S, Huang K, Wang Y, Li H, Tang T. Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis. Bone Res 2022;10:26. [PMID: 35260560 DOI: 10.1038/s41413-022-00198-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Komorita Y, Iwase M, Fujii H, Ide H, Ohkuma T, Jodai-Kitamura T, Sumi A, Yoshinari M, Nakamura U, Kitazono T. The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry. Diabetes Res Clin Pract 2018;146:202-10. [PMID: 30391334 DOI: 10.1016/j.diabres.2018.10.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
368 Novak D, Forsander G, Kristiansen E, Svedlund A, Magnusson P, Swolin-Eide D. Altered cortical bone strength and lean mass in young women with long-duration (19 years) type 1 diabetes. Sci Rep 2020;10:22367. [PMID: 33353965 DOI: 10.1038/s41598-020-78853-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
369 Wang R, Gao D, Zhou Y, Chen L, Luo B, Yu Y, Li H, Hu J, Huang Q, He M, Peng W, Luo D. High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1. J Steroid Biochem Mol Biol 2017;174:276-83. [PMID: 29030155 DOI: 10.1016/j.jsbmb.2017.10.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
370 Alessi J, de Oliveira GB, Schaan BD, Telo GH. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. Diabetol Metab Syndr 2020;12:80. [PMID: 32922517 DOI: 10.1186/s13098-020-00583-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
371 Romero-Díaz C, Duarte-Montero D, Gutiérrez-Romero SA, Mendivil CO. Diabetes and Bone Fragility. Diabetes Ther 2021;12:71-86. [PMID: 33185853 DOI: 10.1007/s13300-020-00964-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
372 Huang X, Shu H, Ren C, Zhu J. SIRT3 improves bone regeneration and rescues diabetic fracture healing by regulating oxidative stress. Biochem Biophys Res Commun 2022;604:109-15. [PMID: 35303676 DOI: 10.1016/j.bbrc.2022.03.001] [Reference Citation Analysis]
373 Han S, Jang HD, Nah S, Han K, Lim H, Kim WS, Hong JY. Effects of changes in regular physical activity status on hip fracture: A nationwide population-based cohort study in Korea. PLoS One 2021;16:e0249819. [PMID: 33831083 DOI: 10.1371/journal.pone.0249819] [Reference Citation Analysis]
374 Eckhardt BA, Rowsey JL, Thicke BS, Fraser DG, O'Grady KL, Bondar OP, Hines JM, Singh RJ, Thoreson AR, Rakshit K, Lagnado AB, Passos JF, Vella A, Matveyenko AV, Khosla S, Monroe DG, Farr JN. Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes. JCI Insight 2020;5:135236. [PMID: 32267250 DOI: 10.1172/jci.insight.135236] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
375 Yu J, Shi YC, Ping F, Li W, Zhang HB, He SL, Zhao Y, Xu LL, Li YX. Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics. Front Endocrinol (Lausanne) 2021;12:763646. [PMID: 34975749 DOI: 10.3389/fendo.2021.763646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]